Xenografts of expanded primate olfactory ensheathing glia support	1
Xenografts	1
expanded primate olfactory ensheathing glia support	15
transient behavioral recovery	67
serotonergic or corticospinal axonal regeneration	120
nude rats following spinal cord transection J.D. Guest	173
nude rats	173
spinal cord transection J.D. Guest	193
b	232
L. Herrera	237
b , I. Margitich b , M. Oliveria b , A. Marcillo b , C.E. Casas	248
b , I. Margitich b	248
M. Oliveria b	267
A. Marcillo b	282
C.E. Casas	297
a Department	310
Neurological Surgery , University of Miami , Miami , FL , USA b Miami Project	326
Neurological Surgery	326
University of Miami , Miami , FL , USA b Miami Project	348
University	348
Miami , Miami , FL , USA b Miami Project	362
Miami , Miami , FL	362
USA b Miami Project	380
Paralysis	408
University of Miami , Miami , FL	419
University	419
Miami , Miami , FL	433
USA Abstract Transplantation of olfactory ensheathing	451
USA Abstract Transplantation	451
olfactory ensheathing	484
OEG	519
the outcome	536
spinal cord injury	553
Proof-of-principle studies in primates	573
Proof-of-principle studies	573
primates	603
the feasibility and efficacy of using in vitro expanded OEG	630
the feasibility and efficacy	630
OEG	686
An intermediate step	708
the validation of rodent studies and human clinical trials	737
the validation	737
rodent studies and human clinical trials	755
rodent studies	755
human clinical trials	774
primate OEG -LRB- POEG -RRB- xenografts in immunotolerant rodents	817
primate OEG -LRB- POEG -RRB- xenografts	817
POEG	830
immunotolerant rodents	850
this study	877
the time course to generate purified POEG	888
POEG	925
their survival	955
effect on damaged axons of the corticospinal and serotonergic systems	971
effect	971
damaged axons of the corticospinal and serotonergic systems	981
damaged axons	981
the corticospinal and serotonergic systems	998
tissue sparing	1042
chronic locomotor recovery following transplantation	1062
chronic locomotor recovery	1062
transplantation	1099
Fiftyseven nude rats	1116
T9/10 spinal cord transection	1147
T9/10	1147
spinal cord transection	1153
Thirty-eight rats	1178
POEG	1205
19 controls	1211
cell medium	1242
10	1259
lentivirally-GFP-transfected POEG	1271
Histological evaluation	1306
6 weeks , 8 weeks , 14 weeks and 23 -- 24 weeks	1347
6 weeks	1347
8 weeks	1356
14 weeks	1365
23 -- 24 weeks	1378
23	1378
24 weeks	1381
these 57 rats	1394
18	1409
5-HT immunostaining , 16 with BDA anterograde CST labeling	1430
5-HT immunostaining	1430
16 with BDA anterograde CST labeling	1451
16	1451
BDA anterograde CST labeling	1459
six	1493
transmission electron microscopy	1511
grafted animals	1548
behavioral recovery , sprouting	1565
behavioral recovery	1565
limited regeneration of 5-HT fibers	1600
limited regeneration	1600
5-HT fibers	1624
increased numbers	1641
proximal collateral processes but not regeneration	1662
proximal collateral processes	1662
regeneration	1700
CST fibers	1716
animals	1749
less	1761
cavitation in the spinal cord stumps than controls	1766
cavitation	1766
the spinal cord stumps than controls	1780
the spinal cord stumps	1780
controls	1808
Behavioral recovery	1818
three months	1848
Five POEG-transplanted animals that had shown behavioral recovery	1880
Five POEG-transplanted animals	1880
behavioral recovery	1926
retransection and behavioral scores	1956
retransection	1956
behavioral scores	1974
long tract axonal regeneration	2038
long tract	2038
axonal regeneration	2049
the locomotor improvement	2089
the ultrastructural level	2119
presumptive POEG	2145
direct contacts	2181
astrocytes	2202
the glia limitans , distinct from those formed by Schwann cells	2221
the glia limitans	2221
those formed by Schwann cells	2254
those	2254
Schwann cells	2270
6 weeks	2288
GFP expression	2296
cells within the lesion site	2327
cells	2327
the lesion site	2340
nerve roots	2367
the pattern of Hoechst nuclear labeling	2397
the pattern	2397
Hoechst nuclear labeling	2412
3.5 months	2441
only GFP-positive debris in macrophages	2452
only GFP-positive debris	2452
macrophages	2480
POEG support	2524
behavioral recovery	2537
mechanisms that appear to be independent	2561
mechanisms	2561
long tract regeneration	2605
Introduction OEGs	2630
promising candidate cells	2652
therapeutic transplantation	2682
spinal cord injury	2720
Ramon-Cueto and Nieto-Sampedro ,1994	2740
Ramon-Cueto	2740
Nieto-Sampedro ,1994	2756
Li et al. , 1997 , 1998 , 2003a , b	2777
Li	2777
et al. , 1997 , 1998 , 2003a , b	2780
et al.	2780
1997	2788
1998	2794
2003a	2800
b	2806
Ramon-Cueto et al. , 1998	2809
Ramon-Cueto	2809
et al. , 1998	2821
et al.	2821
1998	2829
Navarro et al. , 1999	2835
Navarro	2835
et al. , 1999	2843
et al.	2843
1999	2851
Taylor et al. , 2001	2857
Taylor	2857
et al. , 2001	2864
et al.	2864
2001	2872
Pascual et al. , 2002	2878
Pascual	2878
et al. , 2002	2886
et al.	2886
2002	2894
Keyvan-Fouladi et al.	2900
Keyvan-Fouladi	2900
et al.	2915
2003 , 2005	2923
2003	2923
2005	2929
Barnett et al. , 2000	2935
Barnett	2935
et al. , 2000	2943
et al.	2943
2000	2951
Franklin , 2002	2957
Franklin	2957
2002	2967
Santos-Benito and Ramon-Cueto , 2003	2973
Santos-Benito and Ramon-Cueto	2973
2003	3004
Andrews and Stelzner , 2004	3010
Andrews and Stelzner	3010
2004	3032
Fouad et al. , 2005	3038
Fouad	3038
et al. , 2005	3044
et al.	3044
2005	3052
Garcia-Alias et al. , 2004	3058
Garcia-Alias	3058
et al. , 2004	3071
et al.	3071
2004	3079
Sasaki et al. , 2004	3085
Sasaki	3085
et al. , 2004	3092
et al.	3092
2004	3100
Lopez-Vales et al.	3106
Lopez-Vales	3106
et al.	3118
2006 , 2007	3126
2006	3126
2007	3132
They	3139
the central nervous system -LRB- CNS -RRB-	3175
the central nervous system	3175
CNS	3203
Lakatos	3209
et al.	3217
2000 , 2003a , b	3225
2000	3225
2003a	3231
b	3237
Verdu et al. , 2001	3240
Verdu	3240
et al. , 2001	3246
et al.	3246
2001	3254
Nieto - Sampedro , 2003	3260
Nieto	3260
Sampedro , 2003	3267
Sampedro	3267
2003	3277
Barnett , 2004	3283
Barnett	3283
2004	3292
Ramer et al. , 2004	3298
Ramer	3298
et al. , 2004	3304
et al.	3304
2004	3312
Fairless et al. , 2005	3318
Fairless	3318
et al. , 2005	3327
et al.	3327
2005	3335
Li et al.	3341
Li	3341
et al.	3344
2004	3352
astrocytes	3375
inhibitory basal lamina	3397
Schwann cell -LRB- SC -RRB- transplantation	3443
Schwann cell -LRB- SC -RRB-	3443
Schwann cell	3443
SC	3457
Guest et al. , 1997a , b ; Plant et al. , 2001	3478
Guest	3478
et al. , 1997a , b ; Plant et al. , 2001	3484
et al.	3484
1997a	3492
b ; Plant et al.	3498
b	3498
Plant et al.	3501
Plant	3501
et al.	3507
2001	3515
channels	3533
growth -LRB- Li et al. , 2005a , b , 2003a , b -RRB-	3570
growth	3570
Li	3578
et al. , 2005a , b , 2003a , b	3581
et al.	3581
2005a	3589
b	3595
2003a	3598
b	3604
Neuroprotective tissue sparing effects	3608
Takami et al. , 2002 ; Garcia-Alias et al. , 2004	3676
Takami	3676
et al. , 2002 ; Garcia-Alias et al. , 2004	3683
et al. , 2002	3683
et al.	3683
2002	3691
Garcia-Alias et al. , 2004	3697
Garcia-Alias	3697
et al. , 2004	3710
et al.	3710
2004	3718
The clinical efficacy and safety of OEGs	3724
The clinical efficacy and safety	3724
OEGs	3760
Dobkin	3793
et al. , 2006	3800
et al.	3800
2006	3808
Feron et al. , 2005	3814
Feron	3814
et al. , 2005	3820
et al.	3820
2005	3828
Guest et al. , 2006	3834
Guest	3834
et al. , 2006	3840
et al.	3840
2006	3848
Huang et al. , 2006	3854
Huang	3854
et al. , 2006	3860
et al.	3860
2006	3868
Lima et al. , 2006	3874
Lima	3874
et al. , 2006	3879
et al.	3879
2006	3887
lack of standardization of cell preparations	3908
lack	3908
standardization of cell preparations	3916
standardization	3916
cell preparations	3935
Most studies	3954
rodent cells	3981
the importance of testing the properties of primate and human OEG	3998
the importance	3998
the properties of primate and human OEG	4024
the properties	4024
primate and human OEG	4042
clinical implementation	4073
This	4123
autotransplantation	4152
only small tissue quantities	4189
host olfactory tissue	4242
expansion	4301
The properties of such expanded primate OEG	4312
The properties	4312
such expanded primate OEG	4330
such	4330
primate OEG	4344
OEGs derived from the nasal cavity	4389
OEGs	4389
the nasal cavity	4407
a possible alternative source	4428
Au and Roskams	4460
2003	4476
Bianco	4482
et al. , 2004	4489
et al.	4489
2004	4497
Field et al. , 2003	4503
Field	4503
et al. , 2003	4509
et al.	4509
2003	4517
Lu et al. , 2001 , 2002	4523
Lu	4523
et al. , 2001 , 2002	4526
et al.	4526
2001	4534
2002	4540
Au and Roskams , 2003	4546
Au and Roskams	4546
2003	4562
Feron et al. , 2005	4568
Feron	4568
et al. , 2005	4574
et al.	4574
2005	4582
Ito et al. , 2006	4588
Ito	4588
et al. , 2006	4592
et al.	4592
2006	4600
Jani and Raisman , 2004	4606
Jani and Raisman	4606
2004	4624
Marshall et al. , 2006	4630
Marshall	4630
et al. , 2006	4639
et al.	4639
2006	4647
Skinner et al.	4653
Skinner	4653
et al.	4661
2005	4669
the olfactory epithelium -LRB- Herrera et al. , 2005 -RRB-	4699
the olfactory epithelium	4699
Herrera	4725
et al. , 2005	4733
et al.	4733
2005	4741
the human and primate olfactory epithelium	4752
that of rodents	4830
that	4830
rodents	4838
it	4853
only OEG as opposed to SC	4884
only OEG	4884
SC	4907
nasal tissue	4951
the OEG source	4967
ongoing studies	4992
new methods	5039
OEGs	5065
SC	5075
Boyd et al. , 2006 ; Ibanez et al. , 2007 , Rizek and Kawaja , 2006	5079
Boyd et al.	5079
Boyd	5079
et al.	5084
2006 ; Ibanez et al.	5092
2006	5092
Ibanez et al.	5098
Ibanez	5098
et al.	5105
2007	5113
Rizek and Kawaja , 2006	5119
Rizek and Kawaja	5119
2006	5137
this study	5147
the olfactory bulb -LRB- OB -RRB-	5158
the olfactory bulb	5158
OB	5178
OEG	5205
inadvertent culture of SC	5220
inadvertent culture	5220
SC	5243
histological studies	5250
myelinated Schwann cell associated fibers	5291
myelinated Schwann cell	5291
fibers	5326
the OB -LRB- Herrera et al. , 2005 -RRB-	5352
the OB	5352
Herrera	5360
et al. , 2005	5368
et al.	5368
2005	5376
This experiment	5383
methods of immunopurification and cell expansion	5449
methods	5449
immunopurification and cell expansion	5460
rodent OEGs and human SC	5501
rodent OEGs	5501
human SC	5517
POEG , -LRB- Guest et al. , 1997a , b ; Ramon-Cueto et al. , 1998 -RRB-	5558
POEG	5558
Guest	5565
et al. , 1997a , b ; Ramon-Cueto et al. , 1998	5571
et al.	5571
1997a , b ; Ramon-Cueto et al.	5579
1997a , b	5579
1997a	5579
b	5585
Ramon-Cueto et al.	5588
Ramon-Cueto	5588
et al.	5600
1998	5608
the study by Ramon-Cueto	5638
the study	5638
Ramon-Cueto	5651
et al.	5663
Ramon-Cueto	5671
et al. , 2000	5683
et al.	5683
2000	5691
testing	5698
expanded POEGs	5709
the same extent of recovery and repair	5738
the same extent	5738
recovery and repair	5757
long term duration of functional recovery	5786
long term duration	5786
functional recovery	5808
a subset of transplanted spinal cords	5852
a subset	5852
transplanted spinal cords	5864
such recovery	5912
the result of long tract regeneration	5929
the result	5929
long tract regeneration	5943
The ability	5968
transplanted POEG	5983
behavioral recovery and support axonal regeneration following transplantation	6012
behavioral recovery and support axonal regeneration	6012
transplantation	6074
comparison	6106
media-injected spinal transected nude rats	6128
A medium-only control	6172
a cellular control	6208
OEGs	6248
migration	6267
other cell types	6280
SC -LRB- Ramer et al. , 2004 ; Richter et al. , 2005 -RRB-	6305
SC	6305
Ramer	6309
et al. , 2004 ; Richter et al. , 2005	6315
et al.	6315
2004 ; Richter et al.	6323
2004	6323
Richter et al.	6329
Richter	6329
et al.	6337
2005	6345
the ultrastructural interpretation	6367
the baseline extent	6416
SC in-migration associated with the transection and injection procedure itself	6439
SC in-migration	6439
the transection and injection procedure itself	6471
the transection and injection procedure	6471
The majority of the animals in the study	6519
The majority	6519
the animals in the study	6535
the animals	6535
the study	6550
Hoechst-labeled cells	6583
availability of a lentiviral vector	6614
availability	6614
a lentiviral vector	6630
the validity of the Hoechst label	6668
the validity	6668
the Hoechst label	6684
an additional cohort of animalswas transplantedwith cells	6702
an additional cohort	6702
animalswas transplantedwith cells	6726
both Hoechst-labeled and lentivirallytransfected	6769
GFP	6829
Nude rats	6834
our previous experience inwhich	6867
we	6899
human Schwann cells	6932
spinal cord transection sites -LRB- Guest et al. , 1997a , b -RRB-	6957
spinal cord transection sites	6957
Guest	6988
et al. , 1997a , b	6994
et al.	6994
1997a	7002
b	7008
the chronic survival phase	7027
a decline in an initial behavioral recovery and progressive renal pathology	7054
a decline	7054
an initial behavioral recovery and progressive renal pathology	7067
an initial behavioral recovery	7067
progressive renal pathology	7102
these two variables	7144
severity of renal damage	7196
severity	7196
renal damage	7208
declining behavioral function	7241
The response	7272
5-HT and CST pathways	7312
these	7354
clinical importance	7367
rodent OEG transplants -LRB- Keyvan -	7434
rodent OEG transplants	7434
Keyvan	7458
2003	7482
Li et al. ,1997	7488
Li	7488
et al.	7491
,1997	7497
Lu et al.	7504
Lu	7504
et al.	7507
2002	7515
Nash et al.	7521
Nash	7521
et al.	7526
2002	7534
Plant et al.	7540
Plant	7540
et al.	7546
2003	7554
Ramon-Cueto et al.	7560
Ramon-Cueto	7560
et al.	7572
2000	7580
1998	7586
1998	7592
Ramer et al.	7598
Ramer	7598
et al.	7604
2004	7612
Lopez-Vales et al.	7618
Lopez-Vales	7618
et al.	7630
2006	7638
2007 ; Steward et al. , 2006 -RRB-	7644
2007	7644
Steward et al. , 2006 -RRB-	7650
Steward	7650
et al.	7658
2006	7666
The CST	7673
regeneration	7698
die-back	7712
terminal morphology	7722
the presence	7746
collateral processes	7762
Deumens	7784
et al. , 2006	7792
et al.	7792
2006	7800
Lopez-Vales et al. , 2006 , 2007	7806
Lopez-Vales	7806
et al. , 2006 , 2007	7818
et al.	7818
2006	7826
2007	7832
Lu et al. , 2006	7838
Lu	7838
et al. , 2006	7841
et al.	7841
2006	7849
Moreno-Flores et al. , 2006	7855
Moreno-Flores	7855
et al. , 2006	7869
et al.	7869
2006	7877
a correlation between 5-HT fiber regeneration and behavioral recovery	7887
a correlation	7887
5-HT fiber regeneration and behavioral recovery	7909
5-HT fiber regeneration	7909
behavioral recovery	7937
The area of spinal cord cavitation	7971
The area	7971
spinal cord cavitation	7983
the transplanted andmedia-only injected animals	8022
the relationships	8080
transplanted cells	8106
the spinal cord parenchyma containing reactive astrocytes and axons	8129
the spinal cord parenchyma	8129
reactive astrocytes and axons	8167
transmission electron microscopy -LRB- TEM -RRB-	8217
transmission electron microscopy	8217
TEM	8251
Materials and methods All nude rat experiments	8258
Materials	8258
methods All nude rat experiments	8272
methods	8272
All nude rat experiments	8280
approved IACUC protocols in accordance with NIH policy on the humane care	8326
approved IACUC protocols	8326
accordance	8354
NIH policy	8370
the humane care	8384
use of laboratory animals	8404
use	8404
laboratory animals	8411
Use of lentiviral vectors	8431
Use	8431
lentiviral vectors	8438
the University of Miami Institutional Biosafety Committee	8473
the University	8473
Miami Institutional Biosafety Committee	8491
Primate tissue harvest and cell culture Primate olfactory bulbs	8532
Primate tissue harvest and cell culture	8532
Primate olfactory bulbs	8572
following euthanasia in unrelated experiments	8610
following euthanasia	8610
unrelated experiments	8634
the University of Miami tissue sharing program	8664
the University of Miami tissue	8664
Miami	8682
program	8703
The healthy donor primates	8712
age from1 .5 to 10 years -LRB- mean 4.8 + / − 3 years SD -RRB-	8749
age from1 .5 to 10 years	8749
age from1	8749
.5 to 10 years	8758
4.8 + / − 3 years SD	8779
4.8 +	8779
3 years	8785
SD	8793
Twelve primates	8798
Macaca mulata and five were Macaca fascicularis	8819
Macaca	8819
mulata and five	8826
mulata	8826
five	8837
Macaca fascicularis	8847
Therewere 11 males and 6 females with a mean weight of 4.9 + / − 2.2 kg SD .	8868
Therewere	8868
11 males and 6 females with a mean weight of 4.9 + / − 2.2 kg SD .	8878
11 males	8878
6 females with a mean weight of 4.9 + / − 2.2 kg SD .	8891
6 females	8891
a mean weight of 4.9 + / − 2.2 kg SD .	8906
a mean weight	8906
4.9 + / − 2.2 kg SD .	8923
4.9 +	8923
− 2.2	8928
kg SD	8933
The interval from death to tissue recovery	8940
The interval	8940
death to tissue recovery	8958
death	8958
tissue recovery	8967
3 h	8998
viable cells	9006
all specimens	9039
transport to the tissue culture facility	9058
transport	9058
the tissue culture facility	9071
the olfactory bulbs	9099
Liebovitz 's L15 media -LRB- GIBCO -RRB-	9134
Liebovitz 's L15 media	9134
Liebovitz 's	9134
GIBCO	9157
penicillin -LRB- 100 μg/μl -RRB-	9175
penicillin	9175
100 μg/μl	9187
streptomycin -LRB- 100 U/ml -RRB-	9199
streptomycin	9199
100 U/ml	9213
Fungizone	9228
2.5 μg/ml	9239
GIBCO	9250
Invitrogen	9257
ice	9281
dissection on the same day	9291
dissection	9291
the same day	9305
a dissecting microscope	9325
the ventral portion of both olfactory bulbs	9349
the ventral portion	9349
both olfactory bulbs	9372
blood vessels and arachnoid	9424
blood vessels	9424
arachnoid	9442
The amberbrownish nerve fiber layerwas	9453
fromthewhitematter of the remaining olfactory bulb and tract	9507
fromthewhitematter	9507
the remaining olfactory bulb and tract	9529
the remaining olfactory bulb	9529
tract	9562
The dissected tissue	9569
0.05 % collagenase	9605
Worthington Biochemicals Corp.	9624
Freehold	9656
NJ	9666
0.25 %	9674
1.25 U/ml	9681
dispase -LRB- Boehringer Mannheim Biochemicals , Germany -RRB-	9692
dispase	9692
Boehringer Mannheim Biochemicals	9701
Germany	9735
DMEM -LRB- GIBCO , Invitrogen , Carlsbad , CA -RRB-	9747
DMEM	9747
GIBCO	9753
Invitrogen	9760
Carlsbad , CA	9772
10 % heat-inactivated fetal calf serum -LRB- HIFCS -RRB- overnight at 37 °C	9797
10 % heat-inactivated fetal calf serum -LRB- HIFCS -RRB- overnight	9797
10 % heat-inactivated fetal calf serum -LRB- HIFCS -RRB-	9797
10 %	9797
heat-inactivated fetal calf serum -LRB- HIFCS -RRB-	9801
heat-inactivated fetal calf serum	9801
HIFCS	9836
37 °C	9856
5 % CO2	9868
the tissue	9881
a flamenarrowed Pasteur pipette	9915
three times	9957
L-15	9972
the enzymes	9987
The cells	10000
a density of 500,000 cells	10030
a density	10030
500,000 cells	10043
100mmplastic tissue culture dishes	10062
Corning Life Sciences , Acton , MA	10098
Corning Life Sciences	10098
Acton , MA	10121
coatedwith	10132
rat-tail collagen	10154
The cellswere	10173
the mitogens heregulin -LRB- 10 nM , B1 subunit ; a gift from Genentech -RRB-	10198
the mitogens heregulin	10198
10 nM , B1 subunit ; a gift from Genentech	10222
10 nM	10222
B1 subunit ; a gift from Genentech	10229
B1 subunit	10229
a gift from Genentech	10241
a gift	10241
Genentech	10253
forskolin -LRB- 1 μM , Sigma -RRB- in DMEM	10269
forskolin -LRB- 1 μM , Sigma -RRB-	10269
forskolin	10269
1 μM	10280
Sigma	10286
DMEM	10296
10 % HIFCS	10312
The medium	10323
every three days	10346
The cell population	10364
seven days	10401
immunopanning	10421
seven days	10439
a single culture plate	10450
approximately 1.2 million cells	10483
p75 immunopanning	10516
p75 immunopanning	10538
Ramon-Cueto et al. , 1993	10557
Ramon-Cueto	10557
et al.	10569
1993	10577
goat antimouse Ab -LRB- Dako , Ely , UK -RRB-	10583
goat antimouse Ab	10583
Dako	10602
Ely	10608
UK	10613
a concentration of 10 μg/ml in 9 ml of 0.1 M Tris	10620
a concentration	10620
10 μg/ml in 9 ml of 0.1 M Tris	10639
10 μg/ml	10639
9 ml of 0.1 M Tris	10651
9 ml	10651
0.1 M Tris	10659
pH 9.5	10671
plastic Petri dishes -LRB- VWR Scientific Co. , West Chester , PA -RRB-	10694
plastic Petri dishes	10694
VWR Scientific Co.	10716
West Chester	10736
PA	10750
4 °C overnight	10757
4 °C	10757
The following day	10773
the immunopanning dish	10791
three times	10825
0.1 M Tris	10842
pH 9.5	10854
Mouse anti-primate p75	10863
8737 hybridoma supernatant	10887
American Type Culture Collection	10915
Manassas , VA	10949
a dilution of 1:5 in L15	10966
a dilution	10966
1:5 in L15	10980
1:5	10980
L15	10987
the dish at room temperature	11006
the dish	11006
room temperature	11018
1 h.	11039
OB cells	11053
the dish	11080
trypsinization	11092
three times	11128
DMEM	11143
the immunopanning plate	11170
an estimated total of 500,000 cells per 1 ml dish	11198
an estimated total	11198
500,000 cells per 1 ml dish	11220
500,000 cells	11220
1 ml dish	11238
Cells	11248
30 min at 4 °C and then non-adherent cellswerewashed off the dish	11281
30 min at 4 °C	11281
30 min	11281
4 °C	11291
then non-adherent cellswerewashed off the dish	11300
then non-adherent	11300
the dish	11338
The attached cells	11348
the presence of heregulin and forskolin	11384
the presence	11384
heregulin and forskolin	11400
the immunopanning platewas confluent	11430
the immunopanning platewas	11430
They	11468
confluence	11511
transplantation	11536
These third passage cells	11553
culture	11600
a total of approximately 27 -- 33 days	11612
a total of approximately 27	11612
a total	11612
approximately 27	11623
33 days	11640
The cells derived from the two olfactory bulbs of one primate	11649
The cells	11649
the two olfactory bulbs of one primate	11672
the two olfactory bulbs	11672
one primate	11699
3	11725
6 rodent transplantations	11727
the day of transplantation	11757
the day	11757
transplantation	11768
cells	11785
Hoechst -LRB- 33342 , Sigma , 1 μg/ml -RRB-	11809
Hoechst	11809
33342	11818
Sigma	11825
1 μg/ml	11832
Baron-Van Evercooren	11842
et al. , 1991	11863
et al.	11863
1991	11871
They	11878
the collagen-coated dishes	11916
them	11955
trypsin	11963
0.05 % -LRB- GIBCO / BRL -RRB- for 3 min	11971
0.05 % -LRB- GIBCO / BRL -RRB-	11971
0.05 %	11971
GIBCO	11978
BRL	11985
3 min	11994
collagenase -LRB- Type 1 , Worthington Biochemical , -RRB- 0.01 %	12009
collagenase -LRB- Type 1 , Worthington Biochemical , -RRB-	12009
collagenase	12009
Type 1	12022
Worthington Biochemical	12030
Worthington	12030
Biochemical	12042
0.01 %	12056
15 % fetal bovine serum -LRB- FBS -RRB-	12065
15 % fetal bovine serum	12065
FBS	12089
5 min	12098
They	12105
three times	12138
L-15	12155
a hemacytometer using trypan blue exclusion to assess the cell viability	12180
a hemacytometer	12180
trypan blue exclusion	12202
the cell viability	12234
Lentiviral transfection POEG prepared as above	12254
Lentiviral transfection POEG	12254
lentivirus 6/VS-GFP -LRB- courtesy of Dr. Bas Blits -RRB-	12317
lentivirus 6/VS-GFP	12317
courtesy of Dr. Bas Blits	12338
courtesy	12338
Dr. Bas Blits	12350
a vesicular stomatitis virus	12366
replication-incompetent vector	12414
a cytomegalovirus promoter	12455
the Woodchuck post-transcription regulatory element	12498
multiplicity of infection of 50:1	12554
multiplicity	12554
infection of 50:1	12570
infection	12570
50:1	12583
48 h	12589
transplantation	12603
24 h	12626
the cells	12631
three times	12653
DMEM	12670
regular culture media	12679
Fifty-seven adult female nude rats	12715
Taconic , Germantown , NY , NTac : NIH-Whn ,	12751
Taconic , Germantown , NY , NTac	12751
NIH-Whn	12782
140-155 g	12812
intramuscular rat cocktail	12846
ketamine	12874
43 mg/ml	12883
xylazine 8.6 mg	12893
xylazine	12893
8.6 mg	12902
ml ; acepromacine 1.4 mg/ml	12910
ml	12910
acepromacine 1.4 mg/ml	12914
0.5 ml/kg	12941
urinary infection	12963
Kefzol	12981
Cefaxolin sodium ; Eli Lily and Company , Indianapolis	12989
Cefaxolin sodium	12989
Eli Lily and Company , Indianapolis	13007
Eli Lily	13007
Company , Indianapolis	13020
15 mg/100 g body weight	13048
15 mg/100	13048
g body weight	13058
IM	13090
surgery	13102
recovery of spontaneous voiding	13148
recovery	13148
spontaneous voiding	13160
addition	13193
tetracycline -LRB- 1 mg/ml -RRB- and Vitamin C -LRB- 200 mg/L -RRB-	13202
tetracycline -LRB- 1 mg/ml -RRB-	13202
tetracycline	13202
1 mg/ml	13216
Vitamin C -LRB- 200 mg/L -RRB-	13229
Vitamin C	13229
200 mg/L	13240
drinking water	13264
chronic bacterial infection	13291
Baytril -LRB- 15 mg/kg IM bid -RRB-	13323
15 mg/kg IM bid	13332
urinary tract infection -LRB- UTI -RRB-	13369
urinary tract infection	13369
UTI	13394
the survival period	13416
The rats ' core temperature	13437
The rats '	13437
37 + / − 0.5 °C	13482
37 +	13482
0.5 °C	13487
surgery	13501
the immediate post-operative period	13520
all surgery	13557
sterile conditions	13589
A thoracic laminectomy of T9 and T10	13609
A thoracic laminectomy	13609
T9 and T10	13635
the spinal cord	13664
the T9/T10 level	13694
Transections	13712
particular care	13758
the lateral spinal cord	13781
visualization of a gap of approximately 1 mm between the spinal cord stumps	13812
visualization	13812
a gap of approximately 1 mm between the spinal cord stumps	13829
a gap	13829
approximately 1 mm between the spinal cord stumps	13838
approximately 1 mm	13838
the spinal cord stumps	13865
a small sharp microhook	13902
the lateral dural margins	13937
not even thin strands of residual spinal cord	13978
not even thin strands	13978
residual spinal cord	14003
the transection	14047
Thirty-eight animals	14064
a POEG transplant and 19 control animals	14094
a POEG transplant	14094
19 control animals	14116
culture medium -LRB- L-15 -RRB- injections	14144
L-15	14160
control media or cellular injections	14182
control media	14182
cellular injections	14199
the pia mater	14219
a beveled 33 gauge needle	14253
the cell suspension or control mediawas	14286
the cell suspension	14286
control mediawas	14309
a 33 gauge	14343
stainless steel	14354
Hamilton needle	14382
Model 91033	14399
Hamilton Company	14412
Reno , Nevada	14430
a 5 μl syringe held in a Kopf stereotaxic micromanipulator	14456
a 5 μl syringe	14456
a Kopf stereotaxic micromanipulator	14479
The cells	14516
the rostral and caudal stumps	14545
the rostral	14545
caudal stumps	14561
the midline	14578
Ramon-Cueto	14606
et al. -LRB- Ramon - Cueto et al. , 2000 -RRB-	14618
et al.	14618
Ramon	14626
Cueto et al. , 2000	14633
Cueto	14633
et al.	14639
2000	14647
Each animal	14654
a total of 400,000 cells	14675
a total	14675
400,000 cells	14686
50,000 cells in a 0.5 μl volume	14701
50,000 cells	14701
a 0.5 μl volume	14717
four depths -LRB- 200,000 cells/2 μl/stump -RRB-	14750
four depths	14750
200,000 cells/2 μl/stump	14763
200,000	14763
cells/2 μl/stump	14771
Injections	14790
pressure	14814
0.5 μl per minute	14826
0.5 μl	14826
minute	14837
the injection	14851
the needle	14878
the cord over 5 min	14913
the cord	14913
5 min	14927
cell extrusion	14943
the injection site	14963
The ventral dura mater	14983
the dorsal dura materwas	15022
10-0 absorbable sutures -LRB- Ethicon , Somerville , New Jersey -RRB-	15061
10-0 absorbable sutures	15061
Ethicon	15086
Somerville	15095
New Jersey	15107
the 38 POEG-transplanted animals	15123
five	15157
Basso	15169
Beattie , Bresnahan -LRB- BBB -RRB- -LRB- Basso et al. , 1995 -RRB- score	15176
Beattie , Bresnahan -LRB- BBB -RRB- -LRB- Basso et al. , 1995 -RRB-	15176
Beattie , Bresnahan -LRB- BBB -RRB-	15176
Beattie , Bresnahan	15176
BBB	15196
Basso	15202
et al. , 1995	15208
et al.	15208
1995	15216
score	15222
seven	15237
eight weeks	15246
retransection	15289
T9/10	15306
their BBB scores	15317
a subsequent four weeks	15352
Anterograde labeling of the corticospinal tract CST labeling	15377
Anterograde labeling	15377
the corticospinal tract CST labeling	15401
13 transplanted rats	15455
eight controls 17 -- 20 weeks following spinal cord transection	15480
eight controls 17	15480
eight controls	15480
17	15495
20 weeks following spinal cord transection	15498
20 weeks	15498
spinal cord transection	15517
Twenty-one days prior to euthanasia and perfusion the rats	15542
Twenty-one days	15542
euthanasia and perfusion	15567
anesthesia	15611
rat cocktail -LRB- 0.5 ml/kg -RRB-	15627
rat cocktail	15627
0.5 ml/kg	15641
Bilateral craniotomies	15653
a surgical drill and 10 % biotinylated dextran amine -LRB- BDA ,10,000	15694
a surgical drill	15694
10 % biotinylated dextran amine -LRB- BDA ,10,000	15715
10 %	15715
dextran amine -LRB- BDA ,10,000	15732
dextran	15732
amine -LRB- BDA ,10,000	15740
amine	15740
BDA ,10,000	15747
BDA	15747
,10,000	15750
M.W. D1956 , Molecular Probes Inc , Eugene , OR -RRB-	15759
M.W. D1956	15759
Molecular Probes Inc , Eugene , OR -RRB-	15771
Molecular Probes Inc	15771
Eugene	15793
OR	15801
the motor cortex bilaterally -LRB- Guest et al. , 1997a , b -RRB-	15823
the motor cortex bilaterally	15823
the motor cortex	15823
Guest	15853
et al. , 1997a , b	15859
et al.	15859
1997a	15867
b	15873
Five injections of 0.2 μl	15877
Five injections	15877
0.2 μl	15896
side	15922
a depth of 0.7 mmfrom the cortical surface	15930
a depth	15930
0.7 mmfrom the cortical surface	15941
0.7 mmfrom	15941
the cortical surface	15952
The injections	15974
between 1 and 3 mm posterior	16001
the bregma and 2 to 3 mm	16033
the bregma	16033
2 to 3 mm	16048
the midline -LRB- sagittal suture -RRB-	16063
the midline	16063
sagittal suture	16076
Behavioral testing	16094
open field	16114
Nude rats	16125
the open field	16155
Basso	16186
et al. -LRB- Basso et al. , 1995 -RRB- twice prior to surgery	16192
et al. -LRB- Basso et al. , 1995 -RRB-	16192
et al.	16192
Basso	16200
et al. , 1995	16206
et al.	16206
1995	16214
surgery	16235
spinal cord transection	16254
the ratswere	16278
aweek over the entire duration of their survival.Two observers	16305
aweek	16305
the entire duration of their survival.Two observers	16316
the entire duration	16316
their survival.Two observers	16339
a BBB score and then the mean score	16391
a BBB score	16391
the mean score	16412
addition	16444
the open field sessions	16453
further analysis	16498
the animal coding employed	16523
the animal	16523
the testers	16551
they	16579
an OEGtransplanted , or control media-injected rat	16600
an OEGtransplanted	16600
an	16600
control media-injected rat	16623
The scores of transplanted animals versus controls	16651
The scores	16651
transplanted animals versus controls	16665
transplanted animals	16665
controls	16693
two-way ANOVA followed by a Bonferroni	16722
two-way ANOVA	16722
a Bonferroni	16748
multiple comparisons	16786
The scores of the animals	16808
The scores	16808
the animals	16822
retransectionwere assessed using a paired t-test	16847
retransectionwere	16847
a paired t-test	16880
Ascent	16897
a wire mesh ramp A wire mesh grid walk	16907
25 mm × 25 mm	16947
25 mm ×	16947
25 mm	16953
whose angle	16960
ascent	16975
Ramon-Cueto	17014
et al. -LRB- Ramon-Cueto et al. , 2000 -RRB-	17026
et al.	17026
Ramon-Cueto	17034
et al. , 2000	17046
et al.	17046
2000	17054
Control-injected and transplanted rats	17077
Control-injected	17077
transplanted rats	17098
their ability to ascend this ramp once weekly throughout the study	17134
this ramp	17158
weekly throughout the study	17173
weekly	17173
the study	17191
The ramp	17202
45 degrees	17232
the steepest angle	17247
60 , 75 and 90 degrees	17267
60	17267
75	17271
90 degrees	17278
the rats	17299
at least 30 cm within 1 min	17321
at least 30 cm	17321
1 min	17343
a tester blinded to the rat 's control or transplant status	17367
a tester	17367
the rat 's control or transplant status	17387
the rat 's	17387
The maximum ascent angles per session	17427
The maximum ascent angles	17427
session	17457
POEG-transplanted , or controlmedia	17487
POEG-transplanted	17487
controlmedia	17509
rats	17532
Assessment of renal system injury and correlation with BBB scores	17557
Assessment	17557
renal system injury and correlation with BBB scores	17571
renal system injury and correlation	17571
BBB scores	17612
the weight loss and decline in BBB scores of several of the nude rats	17630
the weight loss and decline	17630
BBB scores of several of the nude rats	17661
BBB scores	17661
several of the nude rats	17675
several	17675
the nude rats	17686
complete post-mortem autopsies	17701
one of the authors -LRB- M.O. -RRB- , a qualified veterinarian	17750
one of the authors -LRB- M.O. -RRB-	17750
one	17750
the authors -LRB- M.O. -RRB-	17757
the authors	17757
M.O.	17770
a qualified veterinarian	17777
All organ systems	17803
evidence of gross injury	17839
evidence	17839
gross injury	17851
The renal system	17865
the anterior bladder wall	17898
the kidneys	17935
the plane of their renal calyx	17959
the plane	17959
their renal calyx	17972
Ten animals	17991
urine cultures and renal stoneswere analyzed fromsix animals	18007
urine cultures	18007
renal stoneswere analyzed fromsix animals	18026
renal stoneswere	18026
fromsix animals	18052
A scorewas	18069
grade	18093
the severity of renal damage	18099
the severity	18099
renal damage	18115
the gross level	18139
this	18159
the value	18184
the BBB score decline -LRB- peak BBB score − terminal BBB score -RRB-	18197
the BBB score decline	18197
peak BBB score − terminal BBB score	18220
peak	18220
BBB score − terminal BBB score	18225
BBB score	18225
− terminal BBB score	18234
Spearman 's correlation test	18262
Spearman 's	18262
GraphPad Instat , version 3.05	18293
GraphPad Instat	18293
version 3.05	18310
The severity of renal damage	18324
The severity	18324
renal damage	18340
0 -- 5	18369
the presence of calculi in the bladder -LRB- 1 point -RRB-	18390
the presence	18390
calculi in the bladder -LRB- 1 point -RRB-	18406
calculi	18406
the bladder -LRB- 1 point -RRB-	18417
the bladder	18417
1 point	18430
the kidneys -LRB- 2 points -RRB-	18459
the kidneys	18459
2 points	18472
Renal tissue loss or evidence of infarctionwas	18483
Renal tissue loss or evidence	18483
infarctionwas	18516
from0 -- 3 points	18537
from0	18537
3 points	18543
this scale animals	18559
no calculi and normal appearing kidneys	18583
no calculi	18583
normal appearing kidneys	18598
0 points and those with severe calculi and renal tissue loss score 5 points	18629
0 points and those with severe calculi	18629
0 points	18629
those with severe calculi	18642
those	18642
severe calculi	18653
renal tissue loss score 5 points	18672
renal tissue loss score	18672
5 points	18696
Histological examination of the spinal cord	18706
Histological examination	18706
the spinal cord	18734
survival time points	18753
23 to 24 weeks	18787
six and 16 weeks for GFP-labeled cells	18803
six and 16 weeks	18803
GFP-labeled cells	18824
the rodents	18843
injection	18865
a lethal dose of rat cocktail and then trans-cardiac perfusion with saline	18878
a lethal dose of rat cocktail	18878
a lethal dose	18878
rat cocktail	18895
trans-cardiac perfusion with saline	18917
trans-cardiac perfusion	18917
saline	18946
heparin -LRB- 5000 U.I / L -RRB- followed by 4 %	18964
heparin -LRB- 5000 U.I / L -RRB-	18964
heparin	18964
5000 U.I	18973
L	18982
4 %	18997
paraformaldehyde	19009
perfusion	19037
the transection	19047
thorough inspection of the spinal cord	19088
thorough inspection	19088
the spinal cord	19111
a dissecting microscope	19133
each studied spinal cord	19162
each	19162
spinal cord	19175
a segment	19188
the transection site	19212
10 mm of the rostral and distal spinal cord	19247
10 mm	19247
the rostral and distal spinal cord	19256
the rostral	19256
distal spinal cord	19272
gelatin -LRB- Oudega et al. ,1994 -RRB-	19319
gelatin	19319
Oudega et al. ,1994	19328
Oudega	19328
et al. ,1994	19335
et al.	19335
,1994	19341
KPBS -LRB- 0.1 M -RRB-	19369
KPBS	19369
0.1 M	19375
20 % sucrose	19393
overnight at 4 °C	19405
overnight	19405
4 °C	19418
labeled CST fibers	19434
the transection	19481
the spinal cords	19510
the sagittal or coronal plane at 40 μm	19545
the sagittal or coronal plane	19545
40 μm	19578
a sliding freezingmicrotome	19590
The	19619
the tract terminals	19631
the dorsal	19667
ventral or horizontal plane	19678
both 5-HT immunostaining and comparison of GFP to Hoechst cellular labeling	19711
both 5-HT immunostaining and comparison	19711
GFP to Hoechst cellular labeling	19754
GFP	19754
Hoechst cellular labeling	19761
10 μm sagittal or coronal sections	19787
10 μm sagittal	19787
coronal sections	19805
the left to the right of the spinal cord on a rotatory cryostat	19836
the right of the spinal cord on a rotatory	19848
the right	19848
the spinal cord on a rotatory	19861
the spinal cord	19861
a rotatory	19880
gelatin-coated slides	19929
Specimens	19952
their respective identity as control or transplant	19981
their respective identity	19981
control or transplant	20010
the assessor	20049
Comparison	20063
the distribution of Hoechst and GFP-positive cells Sagittal tissue sections	20077
the distribution of Hoechst	20077
the distribution	20077
Hoechst	20097
GFP-positive cells Sagittal tissue sections	20109
GFP-positive cells	20109
Sagittal tissue sections	20128
appropriate fluorescent wavelengths	20174
a Zeiss Axiophot microscope	20216
a color camera equipped with Neurolucida software	20249
a color camera	20249
Neurolucida software	20278
Image montages	20300
magnifications of 200 × and 400 × and the relative distribution of GFP	20332
magnifications	20332
200 × and 400 × and the relative distribution of GFP	20350
200 × and 400 ×	20350
200 ×	20350
400 ×	20359
the relative distribution of GFP	20368
the relative distribution	20368
GFP	20397
Hoechst-positive cells compared	20405
Hoechst-positive cells	20405
Anti 5-HT	20438
goat-anti-rabbit polyclonal , Incstar Corp , Stillwater , MN	20449
goat-anti-rabbit polyclonal	20449
Incstar Corp	20478
Stillwater	20492
MN	20504
immunostaining	20508
serial 10 μm sagittal or coronal sections	20540
serial 10 μm sagittal	20540
coronal sections	20565
twelve OEG-transplanted and six control rats	20587
six control	20615
The sections	20633
pre-incubation	20662
2 % bovine serum albumin -LRB- Sigma Chemical Co.	20680
bovine serum albumin -LRB- Sigma Chemical Co.	20683
bovine serum albumin	20683
Sigma Chemical Co.	20705
Sigma	20705
Chemical Co.	20711
St. Louis , MO -RRB- and 10 %	20724
St. Louis , MO -RRB-	20724
St.	20724
Louis	20728
MO	20735
10 %	20743
serum in KPBS -LRB- 0.1 M -RRB-	20752
serum	20752
KPBS -LRB- 0.1 M -RRB-	20761
KPBS	20761
0.1 M	20767
non-specific binding	20785
The sections	20807
the anti 5-HT antibodies at a concentration of 1:2000	20841
the anti 5-HT antibodies	20841
a concentration of 1:2000	20869
a concentration	20869
1:2000	20888
KPBS containing 2 % goat serum and 0.1 % Triton-X overnight at 4 °C	20898
KPBS	20898
2 % goat serum and 0.1 % Triton-X overnight at 4 °C	20914
2 % goat serum	20914
0.1 % Triton-X	20932
overnight at 4 °C	20946
overnight	20946
4 °C	20959
three times	20981
KPBS	20998
Secondary antibody -LRB- Alexa Fluor 488 , Molecular Probes -RRB-	21004
Secondary antibody	21004
Alexa Fluor 488 , Molecular Probes	21024
Alexa Fluor 488	21024
Molecular Probes	21041
1 h at room temperature at a 1:100 dilution	21075
1 h	21075
room temperature at a 1:100 dilution	21082
room temperature	21082
a 1:100 dilution	21102
KPBS followed by three washes	21122
KPBS	21122
three washes	21139
immunostaining	21163
the sections	21178
Citifluor -LRB- UKC Chemical laboratory -RRB-	21208
Citifluor	21208
UKC Chemical laboratory	21219
UKC Chemical	21219
laboratory	21232
Digital images	21263
a Zeiss Axiophot microscope	21298
a digital video camera connected to a workstation running Neurolucida software	21331
a digital video camera	21331
a workstation running Neurolucida software	21367
a workstation	21367
Neurolucida software	21389
the relationship between immunopositive fibers and the transection site	21433
the relationship	21433
immunopositive fibers and the transection site	21458
immunopositive fibers	21458
the transection site	21484
image montages	21506
each	21524
the 10 contiguous sections	21532
the greatest density of 5-HT fiber labeling in each spinal cord	21564
the greatest density	21564
5-HT fiber labeling in each spinal cord	21588
5-HT fiber labeling	21588
each spinal cord	21611
Neurolucida	21648
Adobe Photoshop	21681
The number of 5	21698
The number	21698
5	21712
HT positive fibers was linearly correlated with peak BBB scores	21715
HT	21715
positive fibers	21718
peak BBB scores	21763
Assessment for regeneration , die-back , sprouting	21780
Assessment for regeneration	21780
Assessment	21780
regeneration	21795
die-back	21809
terminalmorphology of the labeled CST	21833
terminalmorphology	21833
the labeled CST	21855
confirmation	21876
SCI completeness To identify anterogradely transported BDA in CST processes	21892
SCI completeness To identify anterogradely	21892
BDA in CST processes	21947
BDA	21947
CST processes	21954
the spinal cord segments of thirteen transplanted and eight control animals	21969
the spinal cord segments	21969
thirteen transplanted and eight control animals	21997
thirteen transplanted	21997
eight control animals	22023
gelatin and cut	22062
40 μm sagittal or coronal sections	22098
the entire spinal cord were serially collected into 24	22138
the entire spinal cord	22138
24	22190
The sections	22206
0.5 % hydrogen peroxide -LRB- H2O2 -RRB-	22235
0.5 % hydrogen peroxide	22235
H2O2	22259
30 min	22269
endogenous peroxide	22286
they	22312
biotin peroxidase -LRB- PK-6105 Elite , Vector , Burlingame	22340
biotin peroxidase	22340
PK-6105 Elite	22359
Vector , Burlingame	22374
Ca . -RRB-	22394
Ca	22394
1/800 dilution for 2 h at room temperature	22402
1/800 dilution	22402
2 h at room temperature	22421
2 h	22421
room temperature	22428
The sections	22446
four times	22471
0.25 M Tris	22487
saline	22508
DAB -LRB- 0.04 % -RRB- and NiCl2 -LRB- 0.06 % -RRB-	22535
DAB	22535
0.04 %	22540
NiCl2	22551
0.06 %	22558
20 min	22569
the presence of H2O2 -LRB- 0.015 % -RRB- -LRB- Guest et al. , 1997a , b -RRB-	22579
the presence	22579
H2O2 -LRB- 0.015 % -RRB- -LRB- Guest et al. , 1997a , b -RRB-	22595
H2O2 -LRB- 0.015 % -RRB-	22595
H2O2	22595
0.015 %	22601
Guest	22610
et al. , 1997a , b	22616
et al.	22616
1997a	22624
b	22630
The position	22634
the labeled CST fibers	22650
terminals , the transection site and any cavities and macrophage clusters	22677
terminals	22677
the transection site	22688
any cavities and macrophage clusters	22713
sequential sections	22767
a Zeiss Axiophot microscope connected to a computer running Neurolucida	22793
a Zeiss Axiophot microscope	22793
a computer running Neurolucida	22834
a computer	22834
Neurolucida	22853
The sequential sections	22866
an autofluorescent image montage	22909
interpretation of the terminals and fiber sprouts	22956
interpretation	22956
the terminals and fiber sprouts	22974
relation	23009
the transection site	23021
Two additional analyses of these images	23043
Two additional analyses	23043
these images	23070
CST fibers	23108
evidence and quantification of primary collateral formation	23137
evidence and quantification	23137
primary collateral formation	23168
5 mm of the lesion site	23204
5 mm	23204
the lesion site	23212
A primary collateral process	23229
a process that emerged at right angles to a longitudinally-oriented CST process	23273
a process	23273
right angles	23299
a longitudinally-oriented CST process	23315
this analysis	23365
the 10 contiguous sections	23380
the CSTwas	23416
BDA in each animal	23453
BDA	23453
each animal	23460
The number of longitudinally-oriented processes	23487
The number	23487
longitudinally-oriented processes	23501
at least 150 μm	23535
length in each section and the total number of perpendicular processes	23554
length in each section	23554
length	23554
each section	23564
the total number of perpendicular processes	23581
the total number	23581
perpendicular processes	23601
a definite continuity	23634
the longitudinal process	23678
the primary collateral branch emerging from it	23707
the primary collateral branch	23707
it	23751
Hirata and Fujisawa	23768
1999	23789
The total number of such processes	23796
The total number	23796
such processes	23816
two regions : 0 -- 2.5 mm , and 2.5 to 5.0 mm rostral	23857
two regions	23857
0	23870
2.5 mm	23872
2.5 to 5.0 mm rostral	23884
the transection site	23909
the number	23940
definite primary collateral processes per longitudinal process per mm	23954
definite primary collateral processes	23954
longitudinal process per mm	23996
longitudinal process	23996
mm	24021
this	24028
a ratio	24050
it	24059
the fact	24097
the total number of labeled CST fibers	24111
the total number	24111
labeled CST fibers	24131
animals	24166
CST terminals	24185
round , fusiform , and filopodial	24218
round	24218
fusiform	24225
filopodial	24239
Hill et al. , 2004	24267
Hill	24267
et al.	24272
2004	24280
addition	24290
en-passant varicosities	24299
at least 20 μm of axon	24342
at least 20 μm	24342
axon	24360
either side of the distension	24368
either side	24368
the distension	24383
numbers of a	24426
numbers	24426
a	24437
round , b	24440
round	24440
b	24447
fusiform + filopodial CST terminals and c	24450
fusiform	24450
filopodial CST terminals and c	24459
longitudinal fibers or collateral branches	24531
the five terminal mm of BDA anterograde	24590
the five terminal mm	24590
five	24594
BDA anterograde	24614
CST of control and OEG-transplanted rats	24637
CST	24637
control and OEG-transplanted rats	24644
Assessment	24679
transplanted POEG	24734
loss of parenchyma fromthe spinal cord stumpswe	24760
loss	24760
parenchyma fromthe spinal cord stumpswe	24768
parenchyma fromthe	24768
the volume of cavitieswithin	24818
the volume	24818
cavitieswithin	24832
the parenchyma in a subset of control injected -LRB- n = 5 -RRB-	24847
the parenchyma in a subset of control injected	24847
the parenchyma	24847
a subset of control injected	24865
a subset	24865
control injected	24877
control	24877
n	24895
5	24897
POEG -LRB- n = 5 -RRB- transplanted rats	24904
POEG -LRB- n = 5 -RRB-	24904
POEG	24904
n	24910
5	24912
rats	24928
Sagittal sections	24934
at least 5 mm above	24962
at least 5 mm	24962
belowthe transection sitewere examined under autofluorescence	24986
belowthe transection sitewere	24986
autofluorescence	25031
10 × and photomontages	25051
10 ×	25051
photomontages	25059
Neurolucida	25084
.	25096
The region of maximum cavitation	25098
The region	25098
maximum cavitation	25112
every 10 section -LRB- 10 μm thick sections -RRB-	25155
every 10 section	25155
10 μm thick sections	25173
10 μm	25173
thick sections	25179
a distance of 600 μmlaterally -LRB- total 1.2 mm -RRB-	25211
a distance of 600 μmlaterally	25211
a distance	25211
600	25225
total 1.2 mm	25242
total	25242
1.2 mm	25248
Cavities	25256
Neurolucida and the area determined	25287
Neurolucida	25287
the area determined	25303
the area	25303
The 12 area measurements thus obtained	25324
The 12 area measurements	25324
the distance between the sections -LRB- 100 μm -RRB-	25392
the distance	25392
the sections -LRB- 100 μm -RRB-	25413
the sections	25413
100 μm	25427
average volumes of cavitation	25447
average volumes	25447
cavitation	25466
These	25478
a 2	25504
t-test	25515
Instat 3.05	25525
Ultrastructural examination Six animals	25538
Ultrastructural examination	25538
Six animals	25566
3 controls and 3 POEG , transplanted for 8weeks	25579
3 controls and 3 POEG ,	25579
3 controls	25579
3 POEG	25594
8weeks	25619
transmission electron microscopy -LRB- TEM -RRB-	25640
transmission electron microscopy	25640
TEM	25674
A region	25680
the spinal cord stump and associated scar across the transection gap	25699
the spinal cord stump	25699
associated scar across the transection gap	25725
associated scar	25725
the transection gap	25748
2 % glutaraldehyde	25788
1 % osmium	25818
Araldite	25841
toluidine blue	25868
each	25888
animal regions of interest	25899
animal regions	25899
interest	25917
the scar tissue between the stumps	25938
the scar tissue	25938
the stumps	25962
the spinal cord scar interface	25977
the spinal cord	26020
stumps	26036
1 μm plastic sections	26062
ultra-thin sections	26089
a Philips CM10 electron microscope	26142
The EM grids	26178
axons at 1650 ×	26209
axons	26209
1650 ×	26218
20 representative photomicrographs	26228
The	26278
notable structureswere	26298
the initial images	26349
images	26376
6000	26400
14000 ×	26408
Results	26417
1	26430
Culture and immunopanning of primate olfactory ensheathing glia .	26433
Culture and immunopanning	26433
primate olfactory ensheathing glia	26462
A. S-100 -LRB- Dako polyclonal , 1/100 , red -RRB- and p75	26498
A. S-100 -LRB- Dako polyclonal , 1/100 , red -RRB-	26498
A. S-100	26498
Dako polyclonal , 1/100 , red	26508
Dako polyclonal	26508
1/100	26525
red	26532
p75	26541
8737 hybridoma supernatant	26546
American Type Culture Collection	26574
Manassas	26608
VA	26618
green	26622
immunostaining of a primate OEG culture following p-75 immunopanning	26629
immunostaining	26629
a primate OEG culture following p-75 immunopanning	26647
a primate OEG culture	26647
p-75 immunopanning	26679
A large S-100	26699
p75 negative cell -LRB- white arrow -RRB-	26723
p75 negative cell	26723
white arrow	26742
an astrocyte	26762
B. Flat	26776
left , arrowhead	26794
left	26794
arrowhead	26800
the primary cultures	26857
A primate olfactory bulb	26882
axial section	26919
culture	26938
the blood vessels , meninges , and fila olfactoria -LRB- arrow -RRB-	26946
the blood vessels , meninges , and fila olfactoria	26946
the blood vessels	26946
meninges	26965
fila olfactoria	26979
arrow	26996
the nerve fiber layer	27021
the remaining OB	27072
The impact of antip75 immunopanning	27121
The impact	27121
antip75 immunopanning	27135
one week on the total cell numbers in the culture	27170
one week	27170
the total cell numbers in the culture	27182
the total cell numbers	27182
the culture	27208
Data for five preparations	27221
Data	27221
five preparations	27230
Fig. 2 .	27256
Fig.	27256
2	27261
Disparity	27264
distribution	27282
transplanted Hoechst-labeled and lentivirally-transfected primate OEG	27298
transplanted Hoechst-labeled	27298
transplanted	27298
lentivirally-transfected primate OEG	27331
A , B. Phase contrast and fluorescence images of a culture of p75	27369
B. Phase contrast and fluorescence images	27371
a culture of	27416
a culture	27416
primate cells exposed to the eGFP lentiviral vector for 48 h	27448
primate cells	27448
the eGFP lentiviral vector for 48 h	27473
the eGFP lentiviral vector	27473
48 h	27504
a high rate of transfection	27514
a high rate	27514
transfection	27529
The transection site -LRB- arrow -RRB-	27546
The transection site	27546
arrow	27568
characteristic excellent healing between the stumps	27589
characteristic excellent healing	27589
the stumps	27630
D. Hoechst-positive cells within the central canal	27642
D. Hoechst-positive cells	27642
the central canal	27675
a frequent finding	27698
E. Hoechst-labeled POEG-derived cells exposed to GFP lentiviral vector for 48 h	27718
E. Hoechst-labeled POEG-derived cells	27718
GFP lentiviral vector for 48 h	27767
GFP lentiviral vector	27767
48 h	27793
the spinal cord stumps	27821
the animal	27853
42 days	27883
40 μm thick sagittal sections	27892
40 μm	27892
Migration of the lentiviral cells	27932
Migration	27932
the lentiviral cells	27945
the transection gap	28002
the pial surface	28029
nerve roots	28055
white box , right side magnified in the right corner inset	28068
white box	28068
right side magnified in the right corner inset	28079
right side	28079
the right corner inset	28103
the right corner	28103
The Hoechst-positive region	28128
the GFP-positive region and Hoechst-positive cells	28172
the GFP-positive region	28172
Hoechst-positive cells	28200
rostral in the central canal -LRB- white box , left -RRB-	28233
rostral	28233
the central canal -LRB- white box , left -RRB-	28244
the central canal	28244
white box , left	28263
white box	28263
GFP	28285
the characteristic microcavitation	28304
the spinal cord stumps	28346
Bar	28370
0.8 mm	28374
Fig. 3 .	28383
Fig.	28383
3	28388
POEG-transplanted animals	28391
superior behavioral recovery	28422
A. BBB scores	28452
OEG-transplanted -LRB- open triangles -RRB- and media-transplanted	28469
OEG-transplanted -LRB- open triangles -RRB-	28469
media-transplanted	28507
boxes	28534
1 to 20 weeks	28546
spinal cord transection	28570
= pb0 .01 , = pb0 .001 .	28597
= pb0 .01	28597
= pb0 .001	28609
Data from the subset of lentivirally-transfected OEC	28619
Data	28619
the subset of lentivirally-transfected OEC	28629
the subset	28629
lentivirally-transfected OEC	28643
the right BBB scores	28694
a subset of OEGtransplanted animals pre	28718
a subset	28718
OEGtransplanted animals pre	28730
OEGtransplanted animals	28730
retransection	28768
B. Four	28792
digital video frames of a transplanted animal	28815
digital video frames	28815
a transplanted animal	28839
the open field	28864
A weight-supported step	28880
Video	28914
37 frames per second	28936
37 frames	28936
second	28950
every fourth frame	28961
supplemental video	28995
POEG17 BBB	29014
POEG17	29014
BBB	29021
A media-injected control animal	29030
the wire mesh ramp	29081
75 degrees	29103
every fourth frame	29121
supplemental video	29155
POEG30a ramp	29174
POEG30a	29174
ramp	29182
Fig. 4 .	29190
Fig.	29190
4	29195
Chronic renal injury in spinal transected nude rats .	29198
Chronic renal injury	29198
spinal transected nude rats	29222
The kidneys	29251
ureters	29264
bladder from 2 nude rats with chronic transection and transplantation	29276
bladder	29276
2 nude rats with chronic transection and transplantation	29289
2 nude rats	29289
chronic transection and transplantation	29306
A.	29360
the bladder	29363
evidence of distension	29379
evidence	29379
distension	29391
soft and firm masses that consisted of calcium carbonate and oxalate	29415
soft and firm masses	29415
calcium carbonate and oxalate	29454
B	29488
The kidneys	29491
the calyces with cortical and medullary scarring	29520
the calyces	29520
cortical and medullary scarring	29537
This	29570
chronic pyelonephritis and renal calculi formation	29594
Scale marker = mm .	29646
Scale	29646
marker = mm	29652
demarcations .	29663
Renal system injury scores .	29677
Renal system	29677
injury scores	29690
A calculi	29708
the bladder and kidney -LRB- 2 -RRB-	29737
the bladder and kidney	29737
2	29761
renal parenchymal damage	29768
0	29805
total score = 2	29809
total score	29809
2	29821
B	29827
calculi	29829
both the bladder and kidneys -LRB- 2 -RRB-	29857
the bladder	29862
kidneys -LRB- 2 -RRB-	29878
kidneys	29878
2	29887
the renal parenchymal injury	29894
severe -LRB- 3 -RRB- , total score = 5	29926
-LRB- 3 -RRB- , total score = 5	29933
, total score	29936
5	29950
Fig. 5 .	29954
Fig.	29954
5	29959
Serotonergic fiber regeneration .	29962
Serotonergic fiber	29962
regeneration	29981
A. Anti-5-HT immunostaining	29995
the spinal cord six months	30026
the spinal cord	30026
six months	30042
OEG transplantation	30059
A representative animal with fairly severe cavitation	30080
A representative animal	30080
fairly severe cavitation	30109
the transection site	30146
this cavitation	30185
there	30202
no die-back of 5-HT fibers	30211
no die-back	30211
5-HT fibers	30226
a considerable number of sprouts	30242
a considerable number	30242
sprouts	30267
the cavities and at the margin of the transection site	30299
the cavities	30299
the margin	30319
the transection site	30333
Rostral	30355
the left	30369
B. Magnified region of central box in A .	30379
B. Magnified region of central box	30379
B. Magnified region	30379
central box	30402
A lengthy fiber	30420
the distal spinal cord stump	30469
C. Magnified region of distal box in A .	30499
C. Magnified region of distal box	30499
C. Magnified region	30499
distal box	30522
A fiber	30539
the distal end of the section , a distance of 7.1 cm	30564
the distal end	30564
the section , a distance of 7.1 cm	30582
the section	30582
a distance of 7.1 cm	30595
a distance	30595
7.1 cm	30609
Bar	30617
2.5 mm	30621
Fig. 6 .	30630
Fig.	30630
6	30635
Anterogradely-labeled CST images .	30638
Anterogradely-labeled CST	30638
images	30664
A	30672
A Neurolucida photomontage	30675
a transected spinal cord segment	30705
the composite anterograde BDA label from 12 sections	30749
the composite anterograde BDA label	30749
12 sections	30790
Bar	30821
2 mm	30825
B. Bilateral labeling in the cerebral cortex of the nude rat	30831
B. Bilateral labeling	30831
the cerebral cortex of the nude rat	30856
the cerebral cortex	30856
the nude rat	30879
A. C. CST	30901
label in the medulla of the same animal	30911
label	30911
the medulla of the same animal	30920
the medulla	30920
the same animal	30935
D. Collateral branches emerging from rostral intact CST fibers ,	30952
D. Collateral branches	30952
rostral intact CST fibers	30989
100 μm	31020
Fig. 7 .	31029
Fig.	31029
7	31034
Transmission electron micrographs .	31037
Transmission	31037
electron micrographs	31050
A. From the lesion site of an animal	31072
A.	31072
the lesion site of an animal	31080
the lesion site	31080
an animal	31099
OEG -LRB- 6600 × -RRB-	31127
OEG	31127
6600 ×	31132
Cells with dark cytoplasm	31140
Cells	31140
dark cytoplasm	31151
ensheath	31178
myelinate axons in this fascicle	31198
myelinate axons	31198
this fascicle	31217
The ensheathment	31232
Schwann cells	31274
Basal lamina	31289
the outer membrane surfaces -LRB- black arrow -RRB-	31316
the outer membrane surfaces	31316
black arrow	31345
The fascicle	31359
a typical perineurial cellular process -LRB- white arrow -RRB-	31389
a typical perineurial cellular process	31389
white arrow	31429
B.	31443
the proximal stump , lesion site interface -LRB- 9500 × -RRB-	31451
the proximal stump	31451
lesion site interface -LRB- 9500 × -RRB-	31471
lesion site interface	31471
9500 ×	31494
An large axon with thick peripheral myelin -LRB- white asterisk -RRB-	31502
An large axon	31502
thick peripheral myelin -LRB- white asterisk -RRB-	31521
several astrocyte processes and unmyelinated axons	31594
several astrocyte processes	31594
unmyelinated axons	31626
A cell with thin strands of dark cytoplasm	31646
A cell	31646
thin strands of dark cytoplasm	31658
thin strands	31658
dark cytoplasm	31674
small axons	31708
the presence of microtubules , dark asterisk	31735
the presence	31735
microtubules , dark asterisk	31751
microtubules	31751
dark asterisk	31765
contacts astrocyte	31789
basal lamina -LRB- white arrow -RRB-	31843
basal lamina	31843
white arrow	31857
The cell with thin	31874
The cell	31874
dark cytoplasm	31902
zonula-type junctions with astrocyte processes -LRB- small asterisk -RRB-	31921
zonula-type junctions	31921
astrocyte processes -LRB- small asterisk -RRB-	31948
astrocyte processes	31948
small asterisk	31969
These junctions	31985
those	32016
the astrocyte processes -LRB- large asterisk -RRB-	32047
the astrocyte processes	32047
large asterisk	32072
the 57 animals in the study	32093
the 57 animals	32093
the study	32111
Five transplanted and four control animals	32122
Five transplanted	32122
four control animals	32144
the end-point	32179
purposes of histological analysis	32211
purposes	32211
histological analysis	32223
chronic renal damage	32264
Five other animals	32305
a minor degree	32334
autotomy	32352
Richter	32362
et al. , 2005	32370
et al.	32370
2005	32378
1	32393
a control injection and 4	32399
a control injection	32399
4	32423
OEG injections	32429
The overall incidence of autotomy	32445
The overall incidence	32445
autotomy	32470
9 %	32483
The odds ratio transplant : control ,	32487
The odds ratio transplant	32487
control	32513
2.1 which was not statistically significant p = 0.66	32526
2.1	32526
statistically significant p = 0.66	32544
statistically significant p	32544
0.66	32572
Cultures	32578
primate olfactory bulb-derived cells	32590
A primate olfactory bulb with attached tissues	32627
A primate olfactory bulb	32627
attached tissues	32657
Fig. 1C	32692
The initial cell yield per gram of dissected primate olfactory bulb	32701
The initial cell yield	32701
gram of dissected primate olfactory bulb	32728
gram	32728
dissected primate olfactory bulb	32736
8000 + / − 3000 cells per mg starting tissue	32773
8000 +	32773
3000 cells	32780
mg	32795
tissue	32807
Immunopanning	32815
the percent p75	32855
positive cells from 43 % ± 11 % pre-panning	32871
positive cells	32871
43 % ± 11 % pre-panning	32891
43 %	32891
± 11 %	32894
85 % ± 9 % post-panning -LRB- Fig. 1D -RRB-	32914
85 % ± 9 % post-panning	32914
85 %	32914
± 9 %	32917
Fig. 1D	32935
two distinctive morphologies of primate OEG	32945
two distinctive morphologies	32945
primate OEG	32977
a spindly Schwann	33004
Fig. 1A , B	33033
Fig. 1A	33033
B	33040
a flatter `` astrocyte-like '' appearance -LRB- Fig. 1A , B. -RRB- The latter	33047
a flatter `` astrocyte-like '' appearance -LRB- Fig. 1A , B. -RRB-	33047
a flatter	33047
`` astrocyte-like '' appearance -LRB- Fig. 1A , B. -RRB-	33057
`` astrocyte-like '' appearance	33057
Fig. 1A	33086
B.	33093
The latter	33097
other investigators	33130
rodent cells	33159
van den Pol and Santarelli	33173
van den Pol	33173
Santarelli	33189
2003 ; Vincent et al. , 2003	33201
2003	33201
Vincent et al. , 2003	33207
Vincent	33207
et al. , 2003	33215
et al.	33215
2003	33223
the current study	33233
these	33252
astrocyte-like cells	33259
S-100	33294
some	33310
p75	33320
others	33337
immunopanning	33368
p75 immunopanning	33424
these cells	33458
Anti-p75 immunopanning performed at seven days	33471
Anti-p75 immunopanning	33471
seven days	33507
a considerable overall cell loss	33530
Fig. 1D	33581
This cell loss	33590
it	33610
the cell culture	33633
an additional two to three weeks	33654
sufficient cells	33706
transplantation	33727
Graft composition The composition and viability of the cellular transplants	33744
Graft composition The composition	33744
Graft composition	33744
The composition	33762
viability of the cellular transplants	33782
viability	33782
the cellular transplants	33795
completion of the transplantation procedure	33838
completion	33838
the transplantation procedure	33852
an aliquot of the cellular suspension	33893
an aliquot	33893
the cellular suspension	33907
the Hamilton syringe	33936
a collagen-coated Aclar hat	33962
This	33991
assessment	34004
p75 positive cell survival	34018
the suspension preparation	34055
maintenance on ice for approximately 2.5 h	34083
maintenance	34083
ice for approximately 2.5 h	34098
ice	34098
approximately 2.5 h	34106
injection	34131
the 33 gauge needle	34149
Itwas	34170
9 -- 14 % of the total cells	34187
9 -- 14 %	34187
9	34187
the total cells	34196
viable -LRB- did not exclude trypan blue -RRB-	34221
viable	34221
trypan blue	34245
preparation and extrusion	34264
the syringe	34295
The transplanted cellular suspensions varied from 83	34308
The transplanted cellular suspensions	34308
83	34358
96 % p75	34361
96 %	34361
p75	34365
other experiments	34382
our laboratory	34400
almost all of the non-p75 positive cells	34434
almost all	34434
the non-p75 positive cells	34448
fibronectin-positive putative fibroblasts	34479
J. Guest , unpublished data	34522
J. Guest	34522
unpublished data	34532
such cells	34562
many as 4	34595
17 % of the cells in the transplant	34605
17 %	34605
the cells in the transplant	34612
the cells	34612
the transplant	34625
No clear relationship	34641
primate donor age or sex and the cell yields or final p75 purity	34679
primate donor age or sex	34679
primate donor age	34679
sex	34700
the cell yields or final p75 purity	34708
the cell yields	34708
final p75 purity	34727
GFAP positive astrocytes	34745
the transplanted cellular suspensions	34788
Transfection of	34827
Transfection	34827
POEG	34852
lentivirus Transfection of p75 purified primate OEG cultures with pLenti6	34862
lentivirus Transfection	34862
p75 purified primate OEG cultures with pLenti6	34889
p75	34889
primate OEG cultures	34902
pLenti6	34928
V5-TOPO/gfp	34937
an efficiency of transfection of 90 ±	34961
an efficiency	34961
transfection of 90 ±	34978
transfection	34978
90 ±	34994
5 % at 48 h using an MOI of 50:1 -LRB- Fig. 2A , B -RRB-	34997
5 %	34997
48 h using an MOI of 50:1 -LRB- Fig. 2A , B -RRB-	35003
48 h	35003
an MOI of 50:1 -LRB- Fig. 2A , B -RRB-	35014
an MOI	35014
50:1 -LRB- Fig. 2A , B -RRB-	35024
50:1	35024
Fig. 2A , B	35030
Fig. 2A	35030
B	35038
Behavioral recovery .	35042
field locomotion	35071
All animals	35088
BBB scores of 21	35110
BBB scores	35110
21	35124
pre-training prior	35134
the transection and injection of cells or control media	35156
the transection and injection	35156
cells or control media	35189
Fig. 3A	35225
a statistically significant difference in open field locomotor scores	35233
a statistically significant difference	35233
open field locomotor scores	35275
eight weeks	35319
The BBB scores in both groups	35353
The BBB scores	35353
both groups	35371
12 weeks	35393
The differences between the two groups	35427
The differences	35427
the two groups	35451
significant at 8 , 10 , 12 , 14 , 16 and 18 weeks	35485
8 , 10 , 12 , 14 , 16 and 18	35500
8 weeks	35546
18 weeks	35563
The best transplanted animals	35573
Fig. 3B	35639
they	35652
fore-limb	35664
hind-limb coordination	35677
postural instability	35705
an unusual hopping motion -LRB- see supplemental video POEG 17 BBB -RRB-	35741
an unusual hopping motion	35741
supplemental video POEG 17 BBB	35772
POEG 17 BBB	35791
This	35805
a BBB score of 11	35825
a BBB score	35825
11	35840
No control animals	35844
weight-supported stepping during open field testing	35870
weight-supported	35870
open field testing	35903
Five POEG-transplanted rats	35923
BBB scores	35957
7 or greater for two successive weeks	35977
7 or greater	35977
two successive weeks	35994
retransection	36025
T9/10	36042
one animal	36060
a marked decline in BBB scores but the other four did not -LRB- Fig. 3A -RRB-	36078
a marked decline	36078
BBB scores but the other four did not -LRB- Fig. 3A -RRB-	36098
BBB scores but the other four did not	36098
the other four	36113
Fig. 3A	36137
Mean pre-retransection scores	36147
7.4 + / − 0.55 SD	36182
7.4 +	36182
0.55 SD	36188
post-retransection scores	36205
6.2 + / − 1.9 SD	36236
6.2 +	36236
− 1.9	36241
SD	36246
Paired t-test p value = 0.21 .	36250
Paired t-test p value	36250
The BBB scores of the animals transplanted with lentivirally-transfected cells	36278
The BBB scores	36278
the animals transplanted with lentivirally-transfected cells	36296
the animals	36296
lentivirally-transfected cells	36326
those transplanted with non-transfected cells	36382
those	36382
non-transfected cells	36406
the difference	36433
Behavioral recovery .	36481
B	36502
Ascent of a wire mesh ramp All animals	36506
Ascent	36506
a wire mesh ramp All animals	36516
a wire mesh ramp	36516
All animals	36533
some degree of stepping locomotor activity on the ramp at 45 degrees	36555
some degree	36555
locomotor activity	36579
the ramp at 45 degrees	36601
the ramp	36601
45 degrees	36613
Both the transected control-injected animals and transplanted rats	36625
Both the transected control-injected animals	36625
transplanted rats	36674
motions and ascent of the grid at 60 degrees -LRB- Fig. 3C -RRB-	36711
motions and ascent	36711
the grid at 60 degrees -LRB- Fig. 3C -RRB-	36733
the grid	36733
60 degrees -LRB- Fig. 3C -RRB-	36745
60 degrees	36745
Fig. 3C	36757
Interestingly these stepping movementswere	36767
animals	36827
no	36850
the open field -LRB- see supplemental video POEG30a ramp and POEG30a BBB -RRB-	36865
the open field	36865
supplemental video POEG30a ramp and POEG30a BBB	36885
supplemental video POEG30a ramp	36885
POEG30a BBB	36921
The animals	36935
clonic posterior limb spasms	36962
the grid	37000
Therewas	37010
no statistically significant difference	37019
the angle	37067
POEG-transplanted 63 ± 9.5 and control media-injected rats 54 ± 10.5	37086
POEG-transplanted 63 ± 9.5	37086
POEG-transplanted 63 ±	37086
63	37104
9.5	37107
control media-injected rats 54 ± 10.5	37115
control media-injected rats	37115
54 ±	37143
10.5	37146
movements and ascent of the grid , Student 's 2-tailed test	37170
movements and ascent	37170
the grid , Student 's 2-tailed test	37194
the grid	37194
Student 's 2-tailed test	37204
Student 's	37204
p = 0.06	37229
p	37229
0.06	37231
Correlation of renal pathology with BBB	37237
Correlation	37237
renal pathology with BBB	37252
renal pathology	37252
BBB	37273
scores	37277
autopsy examination of the renal system	37287
autopsy examination	37287
the renal system	37310
all animals	37327
some evidence of chronic bladder distension and renal calculi formation	37346
some evidence	37346
chronic bladder distension and renal calculi formation	37363
Fig. 4A , B	37419
Fig. 4A	37419
B	37427
most animals	37434
no other organ system	37447
notable pathology	37476
three animals	37506
interstitial pneumonia	37520
lung histology	37563
The main differences between animals	37579
The main differences	37579
animals	37608
examination	37631
the kidneys for evidence of chronic pyelonephritis -LRB- Fig. 4A versus B -RRB-	37646
the kidneys	37646
evidence of chronic pyelonephritis -LRB- Fig. 4A versus B -RRB-	37662
evidence	37662
chronic pyelonephritis -LRB- Fig. 4A versus B -RRB-	37674
chronic pyelonephritis	37674
Fig. 4A versus B	37698
Fig. 4A	37698
B	37713
The mean renal pathology score	37717
control animalswas 2.75 ± 1.1	37752
control animalswas	37752
2.75 ± 1.1	37771
2.75	37771
± 1.1	37775
transplantswas	37788
3.0	37803
1.2	37807
Student 's 2 tailed t-test , p = 0.58 -RRB-	37813
Student 's	37813
2	37823
t-test , p = 0.58	37832
t-test	37832
p = 0.58	37840
p	37840
0.58	37842
the peak BBB score less the terminal BBB scores	37853
the peak BBB score	37853
the terminal BBB scores	37877
the renal injury score , those of the transplanted animals	37922
the renal injury score	37922
those of the transplanted animals	37946
those	37946
the transplanted animals	37955
significant correlation -LRB- Spearman 's test , r = 0.79 , p = .003 -RRB-	37999
significant correlation	37999
Spearman 's test , r = 0.79 , p = .003	38024
Spearman 's test	38024
Spearman 's	38024
r = 0.79	38041
r	38041
0.79	38043
p = .003	38049
p	38049
.003	38051
a relation	38074
the decrease in BBB scores and the extent of renal pathology in this sample	38093
the decrease in BBB scores	38093
the decrease	38093
BBB scores	38109
the extent of renal pathology in this sample	38124
the extent	38124
renal pathology in this sample	38138
renal pathology	38138
this sample	38157
such a correlation	38186
control animals -LRB- r = 0.36 , p = 0.25 -RRB-	38222
control animals	38222
r = 0.36 , p = 0.25	38239
r	38239
= 0.36 , p = 0.25	38240
= 0.36 , p	38240
0.36	38241
0.25	38249
this discrepancy	38264
fact	38304
the control animals	38314
the same degree of BBB	38347
the same degree	38347
BBB	38366
recovery	38376
the absolute value of peak minus terminal scores	38389
the absolute value	38389
peak minus terminal scores	38411
peak	38411
terminal scores	38422
Mineral analysis of urinary stones found within the bladder and kidneys	38457
Mineral analysis	38457
urinary stones found within the bladder and kidneys	38477
urinary stones	38477
the bladder and kidneys	38505
the bladder	38505
kidneys	38521
large concretions of magnesium ammonium phosphate and calcium carbonate	38540
large concretions	38540
magnesium ammonium phosphate and calcium carbonate	38561
magnesium ammonium phosphate	38561
calcium carbonate	38594
Urinary cultures	38613
E. coli andMorganella morgani	38648
control animals	38696
stone composition	38730
bacterial organisms	38762
Histological assessment All perfused spinal cords	38783
Histological assessment	38783
All perfused spinal cords	38807
completeness of transection	38886
completeness	38886
transection	38902
each animal	38918
there	38930
a complete absence of visible spinal cord	38940
a complete absence	38940
visible spinal cord	38962
a gap filled by scar tissue as seen in Fig. 2C	38986
a gap	38986
scar tissue	39002
Fig. 2C	39025
Meticulous surgical technique and closure of the dura	39034
Meticulous surgical technique	39034
closure of the dura	39068
closure	39068
the dura	39079
the length	39107
the inter-stump scar -LRB- Zhang et al. , 2004 -RRB-	39121
the inter-stump scar	39121
Zhang	39143
et al. , 2004	39149
et al.	39149
2004	39157
cavities were seen in both control-injected	39167
cavities	39167
transplanted animals -LRB- Verdu et al. , 2003 -RRB-	39215
transplanted animals	39215
Verdu	39237
et al. , 2003	39243
et al.	39243
2003	39251
Fig. 5A	39258
Previous investigators	39268
OEG	39311
the spinal cord stump	39328
the transection site	39355
This questionwas	39377
six animals	39407
the intracellular labels GFP	39427
Hoechst	39460
Hoechstpositive cellswere	39488
the scar tissue of the transection site	39523
the scar tissue	39523
the transection site	39542
the central canal -LRB- Fig. 2D , E -RRB-	39570
the central canal	39570
Fig. 2D , E	39589
Fig. 2D	39589
E	39597
the pia mater	39604
the spinal cord within 5 mm of the transection site	39625
the spinal cord	39625
5 mm of the transection site	39648
5 mm	39648
the transection site	39656
The finding	39678
Hoechst-positive cells within the central canal and on the pia mater	39693
Hoechst-positive cells	39693
the central canal	39723
the pia mater	39748
the extent ofGFP-labeled cells	39792
the extent	39792
ofGFP-labeled cells	39803
considerably fromthat of the Hoechst-labeled cells	39832
considerably fromthat	39832
the Hoechst-labeled cells	39857
the Hoechst-positive cells in the central canal	39892
the Hoechst-positive cells	39892
the central canal	39922
Fig. 2E	39963
Many GFP-positive cells	39973
spinal nerve roots	40016
an elongated morphology -LRB- Fig. 2E -RRB-	40046
an	40046
morphology -LRB- Fig. 2E -RRB-	40059
morphology	40059
Fig. 2E	40071
the cells	40089
the nerve root environment	40118
unpublished data	40146
A large number	40165
macrophageswere present in the transection site at sixweeks and many of these	40183
macrophageswere present in the transection site at sixweeks	40183
macrophageswere present in the transection site	40183
the transection	40210
sixweeks	40234
many of these	40247
many	40247
these	40255
GFP indicating considerable death or engulfment of the transplanted	40297
GFP	40297
considerable death or engulfment of the transplanted	40312
considerable death or engulfment	40312
the transplanted	40348
cells	40377
14 weeks	40387
no discernable GFP-positive transplanted cells	40396
GFP-positive debris in macrophages	40467
GFP-positive debris	40467
macrophages	40490
the anti-human/primate p75 antibody employed in vitro	40536
the anti-human/primate p75 antibody	40536
the fixed tissue of xenografted animals	40610
the fixed tissue	40610
xenografted animals	40630
xenograft survival or cell migration	40679
it	40720
knowif cell death or loss of transgene expression accounts	40739
knowif cell death or loss	40739
transgene expression accounts	40768
this observation	40802
the appearance of the GFP debris	40829
the appearance	40829
the GFP debris	40847
cell death	40881
5-HT immunostaining Serial sequential 10 μm sagittal or coronal sections	40893
10	40931
eleven POEG-transplanted and seven control rats	40971
eleven POEG-transplanted	40971
seven control rats	41000
Indistinct fibers and those less than 100 μm	41033
Indistinct fibers	41033
those less than 100 μm	41055
9	41099
11 POEG	41108
animals	41124
some extension of 5-HT positive processes	41132
some extension	41132
5-HT positive processes	41150
the lesion site	41193
6	41216
11 animals	41225
a few immunolabeled processes	41236
the distal spinal cord	41289
These fibers	41313
the grey matter -LRB- Fig. 5C -RRB-	41350
the grey matter	41350
Fig. 5C	41367
the pia mater at the spinal cord surface	41388
the pia mater	41388
the spinal cord surface	41405
The greatest distance	41430
a labeled processwas	41461
the transection sitewas 6.2 mm -LRB- Fig. 5A , C -RRB-	41501
the transection sitewas 6.2 mm	41501
Fig. 5A , C	41531
Fig. 5A	41531
C	41539
most of the processes	41551
most	41551
the processes	41559
more than 1 mm	41588
the distal spinal cord stump -LRB- Fig. 5A -RRB-	41608
the distal spinal cord stump	41608
Fig. 5A	41638
The mean number of 5-HT positive fibers	41648
The mean number	41648
5-HT positive fibers	41667
the transection site	41707
the 10 contiguous sections with the densest proximal 5-HT	41731
the 10 contiguous sections	41731
the densest proximal 5-HT	41763
21 + / − 11 fibers	41802
21 +	41802
11	41807
fibers	41810
There	41818
no regeneration of 5-HT positive axons in control animals	41828
no regeneration	41828
5-HT positive axons in control animals	41847
5-HT positive axons	41847
control animals	41870
minimal die-back of the tract	41890
minimal die-back	41890
the tract	41910
condition	41943
No evidence of incomplete transection	41954
No evidence	41954
incomplete transection	41969
any section	42007
both the BBB analysis and the 5HT immunostaining analysis	42026
the BBB analysis	42031
the 5HT immunostaining analysis	42052
the number of 5-HT	42103
the number	42103
5-HT	42117
positive fibers distal to the transection site	42122
positive fibers	42122
the transection site	42148
the peak BBB scores of the rats	42189
the peak BBB scores	42189
the rats	42212
No significant correlation	42222
r2 0.02 , p	42263
r2 0.02	42263
p	42272
0.68	42274
BDA anterograde labeling	42280
the CST Ten POEG-transplanted and six control animals	42308
CST Ten	42312
six	42342
the CST	42388
the cortex -LRB- Fig. 6B -RRB- and upper pyramidwere	42412
the cortex -LRB- Fig. 6B -RRB-	42412
the cortex	42412
Fig. 6B	42424
upper pyramidwere	42437
BDA	42467
reaction product -LRB- Fig. 6C -RRB-	42471
reaction product	42471
Fig. 6C	42489
nor	42527
control animals	42531
evidence of CST fiber regeneration	42551
evidence	42551
CST fiber regeneration	42563
the lesion site	42601
no animalwas evidence of incomplete CST injury observed	42630
no animalwas evidence	42630
incomplete CST injury observed	42655
incomplete CST injury	42655
this laboratory 's previous experience	42702
this laboratory 's	42702
human SC grafts -LRB- Guest et al. , 1997a , b -RRB-	42745
human SC grafts	42745
Guest	42762
et al. , 1997a , b	42768
et al.	42768
1997a	42776
b	42782
a significant reduction	42785
die-back	42812
end-bulbs	42835
OEGtransplanted rats	42848
the four month time-point	42872
Fig. 6A	42912
Evidence of primary collateral formation	42922
Evidence	42922
primary collateral formation	42934
CST fibers within 5mmof the lesion	42980
CST fibers	42980
5mmof the lesion	42998
sitewas also assessed -LRB- Fig. 6D -RRB-	43015
sitewas also assessed	43015
sitewas	43015
Fig. 6D	43038
A statistically larger number of primary collateral processes	43048
A statistically larger number	43048
primary collateral processes	43081
POEGtransplanted animals -LRB- 1.4 + / − 0.6 processes per axon/mm -RRB-	43123
POEGtransplanted animals	43123
1.4 +	43149
− 0.6 processes per axon/mm	43154
− 0.6 processes	43154
axon/mm	43173
animals -LRB- 0.7 + / − 0.5 processes per axon/mm -RRB- in the 2.5	43205
animals -LRB- 0.7 + / − 0.5 processes per axon/mm -RRB-	43205
animals	43205
0.7 +	43214
0.5 processes	43220
axon/mm	43238
the 2.5	43250
5.0 mm rostral zone	43259
p = 0.03 two-tailed Student 's t-test	43280
p	43280
= 0.03 two-tailed Student 's t-test	43281
= 0.03	43281
two-tailed Student 's t-test	43287
two-tailed Student 's	43287
the 0 -- 2.5 mm ; where in fact there were few BDA positive processes at all	43327
the 0	43327
2.5 mm ; where in fact there were few BDA positive processes at all	43333
2.5 mm	43333
fact	43350
there	43355
few BDA positive processes	43366
Cavity volumes	43401
The estimated size of spinal cavities	43416
The estimated size	43416
spinal cavities	43438
the transaction region	43466
from6 .84 mm3	43505
3.3 mm3	43520
POEG-transplanted animals	43528
an average volume of 4.5 + / − 0.77 mm3	43558
an average volume	43558
4.5 + / − 0.77 mm3	43579
4.5 +	43579
0.77 mm3	43585
medium	43609
animals	43625
5.9 + / − 0.65 mm3	43633
5.9 +	43633
0.65 mm3	43639
This difference	43649
p	43696
0.01	43698
Ultrastructure	43704
Three transplanted animals and three control animals	43719
Three transplanted animals	43719
three control animals	43750
TEM examination of selected regions from the spinal cord stumps and lesion site	43782
TEM examination	43782
selected regions from the spinal cord stumps and lesion site	43801
selected regions	43801
the spinal cord stumps and lesion site	43823
the three transplanted animals	43866
fascicles containing an interesting mixture of ensheathed and myelinated axons	43898
fascicles	43898
an interesting mixture of ensheathed and myelinated axons	43919
an interesting mixture	43919
ensheathed and myelinated axons	43945
Fig. 7A	43994
The cells	44004
axons	44030
unusual dark cytoplasm but themyelinating cells	44040
unusual dark cytoplasm	44040
themyelinating cells	44067
this appearance	44101
control animals	44121
a small number of fascicles of myelinated axons	44138
a small number	44138
fascicles of myelinated axons	44156
fascicles	44156
myelinated axons	44169
none of the cells that were ensheathing	44209
none	44209
the cells that were ensheathing	44217
the cells	44217
dark cytoplasm	44253
these cells with dark cytoplasm	44285
these cells	44285
dark cytoplasm	44302
opposed to endogenous in-migrating Schwann cells -LRB- Ramer et al. , 2004 -RRB-	44338
opposed to endogenous in-migrating Schwann cells	44338
endogenous in-migrating Schwann	44349
Ramer	44388
et al. , 2004	44394
et al.	44394
2004	44402
the pattern of ensheathment	44422
the pattern	44422
ensheathment	44437
that seen with OEGs as compared to SC	44476
that	44476
OEGs	44491
SC	44511
there	44522
incomplete and scant cytoplasm around the axons	44531
incomplete and scant cytoplasm	44531
the axons	44569
It	44580
there	44600
basal lamina	44610
the surface of ensheathing cells within this fascicle	44626
the surface	44626
ensheathing cells within this fascicle	44641
ensheathing cells	44641
this fascicle	44666
the inner and outer surfaces	44688
the associated perineurial cells	44720
the appearance of fascicles of olfactory nerves	44783
the appearance	44783
fascicles of olfactory nerves	44801
fascicles	44801
olfactory nerves	44814
the lamina propria and fila olfactoria	44838
other adult Macaque primates	44880
our laboratory -LRB- Herrera et al. , 2005 -RRB-	44921
our laboratory	44921
Herrera	44937
et al. , 2005	44945
et al.	44945
2005	44953
Unusual perineurial cellular processes	44960
other authors -LRB- Li et al. ,1998 ; Boyd et al. , 2004 -RRB-	45022
other authors	45022
Li et al. ,1998 ; Boyd et al. , 2004	45037
Li	45037
et al. ,1998 ; Boyd et al. , 2004	45040
et al. ,1998	45040
et al.	45040
,1998	45046
Boyd et al. , 2004	45053
Boyd	45053
et al. , 2004	45058
et al.	45058
2004	45066
the OEGtransplanted spinal cord	45075
many fascicles within the tissue	45117
many fascicles	45117
the tissue	45139
those of peripheral nerve	45160
those	45160
peripheral nerve	45169
novel interactions	45187
the dark cells , unmyelinated axons , and astrocyte processes	45214
the dark cells	45214
unmyelinated axons	45230
astrocyte processes	45254
the three transplanted animals	45293
Fig. 7B	45328
one of these dark cells	45336
one	45336
these dark cells	45343
a probable Schwann cell	45383
white asterisk	45408
several astrocytic processes	45428
e.g. white arrow	45458
e.g.	45458
white arrow	45463
The cytoplasmic processes of one of these cells	45477
The cytoplasmic processes	45477
one of these cells	45506
one	45506
these cells	45513
several small axons -LRB- e.g. black asterisk -RRB-	45553
several small axons	45553
e.g. black asterisk	45574
e.g.	45574
black asterisk	45579
the absence of endo - or perineuria	45598
the absence	45598
endo - or perineuria	45613
This cell	45634
direct contact	45653
astrocyte processes	45673
a punctate adhesion-like structure -LRB- Fig. 7C , small asterisk -RRB-	45711
a punctate adhesion-like structure	45711
Fig. 7C	45747
small asterisk	45756
these membrane appositions	45776
there	45803
no visible basal lamina	45812
Adjacent astrocyte processes	45837
similar punctate adhesions -LRB- Fig. 7C , large asterisk -RRB-	45871
similar punctate adhesions	45871
Fig. 7C	45899
large asterisk	45908
This cell 's processes	45925
This cell 's	45925
astrocytes	45967
the glial	45994
membrane formed in the region of the transection	46013
membrane	46013
the region of the transection	46032
the region	46032
the transection	46046
dark arrow	46063
there	46081
surface basal lamina associated with these astrocytes	46090
surface basal lamina	46090
these astrocytes	46127
The cytoplasmic continuity of the presumed astroglial cellular processes	46145
The cytoplasmic continuity	46145
the presumed astroglial cellular processes	46175
high quality photomicrographs	46243
illumination and magnification	46279
it	46314
they	46336
large cells	46354
extensive intermediate filaments , consistent with reactive astrocytes	46377
extensive intermediate filaments	46377
reactive astrocytes	46427
The cells with dark cytoplasm	46448
The cells	46448
dark cytoplasm	46463
the dense filaments of an astrocyte	46483
the dense filaments	46483
an astrocyte	46506
the dense basal lamina seen on adjacent reactive astrocyte processes	46534
the dense basal lamina	46534
adjacent reactive astrocyte processes	46565
the cells	46612
dark cytoplasm or direct contacts	46627
dark cytoplasm	46627
direct contacts	46645
ensheathing cells	46669
astrocyte processes	46691
animals with medium-only injections	46724
animals	46724
medium-only injections	46737
Discussion Preamble	46761
this study	46784
several important observations related to transplanted POEGs	46795
several important observations	46795
transplanted POEGs	46837
nude rats	46872
primate p75 positive OEGs	46886
the olfactory bulb	46959
the BBB test	46988
a substantial behavioral recovery	47001
immune deficient rats that were transplanted with the xenograft cells	47051
immune deficient rats	47051
the xenograft cells	47101
behavioral recovery	47130
a subset of retransected animals	47184
a subset	47184
retransected animals	47196
this	47218
mechanisms other than regeneration	47238
mechanisms	47238
regeneration	47260
the observed behavioral recovery	47288
behavioral recovery	47325
the BBB scale	47348
time	47382
nude rats	47402
chronic renal injury that may limit their utility in long-term SCI experiments	47436
chronic renal injury	47436
their utility	47472
long-term SCI experiments	47489
the control animals	47519
unexpectedly high scores	47543
the graded angle gridwalk	47571
strong stimulation of sensory afferents	47615
strong stimulation	47615
sensory afferents	47637
the isolated spinal cord	47658
the POEGtransplanted spinal cord	47699
the CST	47732
collateralization and the appearance of the terminals	47747
collateralization	47747
the appearance of the terminals	47769
the appearance	47769
the terminals	47787
regeneration	47802
6	47830
limited regeneration	47847
5-HT fibers	47871
transplanted animals	47899
the extent	47962
behavioral recovery ; 7 -RRB-	47976
behavioral recovery	47976
7	47997
POEG transfection with pLenti6/V5-TOPO/gfp	48000
POEG transfection	48000
pLenti6/V5-TOPO/gfp	48023
their unequivocal identification	48051
a marked difference	48088
the distribution pattern of Hoechst-positive versus GFP-transfected cells	48111
the distribution pattern	48111
Hoechst-positive versus GFP-transfected cells	48139
Hoechst-positive	48139
GFP-transfected cells	48163
GFP-transfected POEG	48195
14 weeks	48241
debris within numerous macrophages	48254
debris	48254
numerous macrophages	48268
extensive death of the transplanted cells	48299
extensive death	48299
the transplanted cells	48318
8	48343
novel cellular interactions of transplanted cells	48346
novel cellular interactions	48346
transplanted cells	48377
the EM level	48413
These observations	48427
OEGs	48492
the olfactory bulb	48544
P75 immunopanningwas	48564
olfactory bulb-derived cultures	48604
OEGs	48640
it	48649
cultures of predominantly p75 positive cells for at least one	48675
cultures	48675
predominantly p75 positive cells for at least one	48687
predominantly p75 positive cells	48687
p75	48701
at least one	48724
month	48737
cell loss intrinsic to the immunopanning process	48753
cell loss	48753
the immunopanning process	48776
the time needed to obtain sufficient cells for transplantation	48812
the time	48812
sufficient cells	48838
transplantation	48859
This finding	48876
the planning of preclinical studies	48913
the planning	48913
preclinical studies	48929
This	48950
an autotransplantation paradigm	48989
even less olfactory tissue	49021
the primary culture	49071
our preparations both cadaveric	49095
our preparations	49095
cadaveric	49117
primate olfactory bulbs	49127
there	49179
as many as 500,000 cells	49196
it	49232
few as 100,000 cells	49253
the initial cell culture	49289
a primate autotransplantation	49317
mitogen expansion	49359
and approximately threeweeks	49402
a p75-enriched cell culture -LRB- 106 cells -RRB- for autotransplantation	49457
a p75-enriched cell culture -LRB- 106 cells -RRB-	49457
a p75-enriched cell culture	49457
106 cells	49486
autotransplantation	49501
Some investigators	49522
p75 selection of OEG cell cultures	49554
p75 selection	49554
OEG cell cultures	49571
the efficacy	49600
a transplanted cell suspension -LRB- Moreno - Flores et al. , 2003 -RRB-	49616
a transplanted cell suspension	49616
Moreno	49648
Flores et al. , 2003	49656
Flores	49656
et al.	49663
2003	49671
OEG phenotype	49686
culture conditions	49715
Franceschini and Barnett , 1996 ; Alexander et al. , 2002 ; Chuah et al. , 2000	49736
Franceschini and Barnett	49736
1996 ; Alexander et al. , 2002 ; Chuah et al.	49762
1996	49762
Alexander et al. , 2002 ; Chuah et al.	49768
Alexander	49768
et al. , 2002 ; Chuah et al.	49778
et al. , 2002	49778
et al.	49778
2002	49786
Chuah et al.	49792
Chuah	49792
et al.	49798
2000	49806
future studies	49812
the impact of culture conditions on OEG survival	49841
the impact	49841
culture conditions on OEG survival	49855
culture conditions	49855
OEG survival	49877
migration	49891
axonal association following transplantation	49906
an alternative source tissue from which to derive OEG	49958
an alternative source tissue	49958
OEG	50008
the olfactory epithelium	50015
Au and Roskams	50041
2003 ; Bianco et al. , 2004 ; Franklin , 2002 ; Lu et al.	50057
2003	50057
Bianco et al. , 2004 ; Franklin , 2002 ; Lu et al.	50063
Bianco	50063
et al. , 2004 ; Franklin , 2002 ; Lu et al.	50070
et al. , 2004	50070
et al.	50070
2004	50078
Franklin , 2002	50084
Franklin	50084
2002	50094
Lu et al.	50100
Lu	50100
et al.	50103
2001	50111
numerous fascicles of SC myelinated axons in the primate lamina propria	50118
numerous fascicles	50118
SC myelinated axons in the primate lamina propria	50140
SC myelinated axons	50140
the primate lamina propria	50163
Herrera et al. , 2005	50210
Herrera	50210
et al.	50218
2005	50226
the extent of our knowledge	50236
the extent	50236
our knowledge	50250
there	50265
no method to separate SC from OEG	50274
no method	50274
separate SC from OEG	50287
separate SC	50287
OEG	50304
they	50313
similar mitogens -LRB- Yan et al. , 2001 -RRB-	50329
similar mitogens	50329
Yan	50347
et al. , 2001	50351
et al.	50351
2001	50359
This	50366
purification of OEG	50377
purification	50377
OEG	50393
the primate olfactory epithelium problematic	50402
the primate olfactory epithelium	50402
currently available techniques	50453
A substantial behavioral recovery measured with the BBB test	50488
A substantial behavioral recovery	50488
the BBB test	50536
immune deficient rats that were transplanted with the xenograft cells	50565
immune deficient rats	50565
the xenograft cells	50615
Some studies	50636
no benefit	50664
behavioral recovery	50678
OEG transplantation -LRB- Takami et al. , 2002 ; Resnick et al. , 2003 -RRB-	50708
OEG transplantation	50708
Takami	50729
et al. , 2002 ; Resnick et al. , 2003	50736
et al.	50736
2002 ; Resnick et al.	50744
2002	50744
Resnick et al.	50750
Resnick	50750
et al.	50758
2003	50766
these studies	50785
OEGs	50799
contusion cavities	50836
survival	50861
this study	50897
transplanted animals	50908
more locomotor behavioral recovery	50944
control-injected animals	50984
limited regeneration of 5-HT axons	51019
limited regeneration	51019
5-HT axons	51043
retransection of the spinal cord in a subset of rats	51068
retransection	51068
the spinal cord in a subset of rats	51085
the spinal cord	51085
a subset of rats	51104
a subset	51104
rats	51116
loss of the recovery of the hind-limbs	51137
loss	51137
the recovery of the hind-limbs	51145
the recovery	51145
the hind-limbs	51161
levels	51187
BBB scores	51211
This	51223
other mechanisms	51242
long tract regeneration	51277
the isolated spinal cord	51322
this recovery	51362
dorsal column	51387
injury OECs	51401
GAP-43	51441
positive fiber growth	51448
the distal lesion site -LRB- Andrews and Stelzner , 2007 -RRB-	51475
the distal lesion site	51475
Andrews and Stelzner	51499
2007	51521
labeled sensory axons	51554
-LRB- Moreno - Flores et al. , 2006 -RRB-	51577
Moreno	51578
Flores et al. , 2006	51586
Flores	51586
et al. , 2006	51593
et	51593
al.	51596
CGRP positive sensory fibers -LRB- Richter et al. , 2005 -RRB-	51634
CGRP	51634
positive sensory fibers -LRB- Richter et al. , 2005 -RRB-	51639
positive sensory fibers	51639
Richter	51664
et al. , 2005	51672
et al.	51672
2005	51680
It	51686
distally transplanted OEGs	51706
sensory afferents	51766
open field stepping through plasticity of the local stepping circuitry	51799
open field	51799
plasticity of the local	51827
plasticity	51827
the local	51841
circuitry	51860
Behavioral recovery measured with the BBB scale	51874
Behavioral recovery	51874
the BBB scale	51908
time	51942
Two possible causes for this	51948
Two possible causes	51948
this	51972
death of transplanted cells , and chronic systemic illness	51993
death of transplanted cells	51993
death	51993
transplanted cells	52002
chronic systemic illness	52026
GFP-positive POEGs	52052
14 weeks	52090
transplantation	52105
42 days	52141
There	52150
little evidence	52159
studies of cell transplantation for SCI	52180
studies	52180
cell transplantation for SCI	52191
cell transplantation	52191
SCI	52216
large numbers	52225
cells	52242
transplanted	52248
the spinal cord	52272
chronic time points	52291
Hill et al. , 2007 ; Pearse et al. , 2007 ; Okada et al. , 2005	52312
Hill	52312
et al. , 2007 ; Pearse et al. , 2007 ; Okada et al. , 2005	52317
et al. , 2007	52317
et al.	52317
2007	52325
Pearse et al. , 2007	52331
Pearse	52331
et al. , 2007	52338
et al.	52338
2007	52346
Okada et al. , 2005	52352
Okada	52352
et al. , 2005	52358
et al.	52358
2005	52366
A delayed cell death	52372
chronic immune rejection	52409
other studies	52438
a decline in behavioral recovery	52464
a decline	52464
behavioral recovery	52477
approximately 40 days	52500
a this effect -LRB- Jones et al. , 2002 -RRB-	52525
a this effect	52525
Jones	52540
et al. , 2002	52546
et al.	52546
2002	52554
nude rats	52567
cellular xenografts	52589
early time points -LRB- Deng et al. , 2006 -RRB-	52612
early time points	52612
Deng	52631
et al. , 2006	52636
et al.	52636
2006	52644
tissue	52654
several months	52665
the anterior chamber of the eye -LRB- Bickford - Wimer et al. , 1987 -RRB-	52683
the anterior chamber	52683
the eye -LRB- Bickford - Wimer et al. , 1987 -RRB-	52707
the eye	52707
Bickford	52716
Wimer et al. , 1987	52726
Wimer	52726
et al.	52732
1987	52740
It	52747
xenograft tolerance of nude rats	52764
xenograft tolerance	52764
nude rats	52787
age -LRB- Maruo et al. ,1982 -RRB-	52813
age	52813
Maruo	52818
et al. ,1982	52824
et al.	52824
,1982	52830
Lentivirus reporter and survival	52837
Ericson	52871
et al. , 2002 ; Blits et al. , 2005	52879
et al.	52879
2002 ; Blits et al.	52887
2002	52887
Blits et al.	52893
Blits	52893
et al.	52899
2005	52907
The long-term presence of the transplanted cells	52914
The long-term presence	52914
the transplanted cells	52940
trophic or structural effects	52963
their death	53015
loss of behavioral gains	53052
loss	53052
behavioral gains	53060
neurocircuitry	53092
This observation	53108
implications for CNS xeno	53136
implications	53136
CNS	53153
allo-graft strategies	53170
the concept	53201
the short-term presence of the cells	53221
the short-term presence	53221
the cells	53248
a stable remodeling of neurocircuitry	53284
a stable remodeling	53284
neurocircuitry	53307
Long term studies	53323
the relationship between cell survival and behavioral recovery	53344
the relationship	53344
cell survival and behavioral recovery	53369
cell survival	53369
behavioral recovery	53387
Spinal transected nude rats	53419
chronic renal injury that may limit their utility in long-term SCI experiments	53471
chronic renal injury	53471
their utility	53507
long-term SCI experiments	53524
The initial plan	53551
the animals	53581
one year	53597
this	53610
progressive nephropathy and modest weight loss	53639
the use of chronic antibiotic therapy	53709
the use	53709
chronic antibiotic therapy	53720
previous studies with shorter survival periods	53751
previous studies	53751
shorter survival periods	53773
nude rats	53804
this problem	53814
Guest	53848
et al. , 1997a , b	53854
et al.	53854
1997a	53862
b	53868
a limitation in the use of nude rats with spinal cord transection	53883
a limitation	53883
the use of nude rats with spinal cord transection	53899
the use	53899
nude rats with spinal cord transection	53910
nude rats	53910
spinal cord transection	53925
progressive renal damage	53952
This progressive pathology which appeared to weaken the animals	53978
This progressive pathology	53978
the animals	54030
an alternative explanation	54054
the degradation of the behavioral recovery	54085
the degradation	54085
the behavioral recovery	54104
A previous study in neurologically intact nude rats -LRB- Miller , 1984 -RRB-	54129
A previous study	54129
neurologically intact nude rats -LRB- Miller , 1984 -RRB-	54149
neurologically intact nude rats	54149
Miller	54182
1984	54190
addition of cyclosporin in the same nude rat strain	54207
addition	54207
cyclosporin in the same nude rat strain	54219
cyclosporin	54219
the same nude rat strain	54234
pyelonephritis	54285
nude rats	54310
a strong reaction	54325
foreign tissue antigens	54346
they	54370
intact humoral immunity -LRB- Vos et al. , 1980 -RRB-	54389
intact humoral immunity	54389
Vos	54414
et al. , 1980	54418
et al.	54418
1980	54426
Spinal cord injury	54433
systemic immunosuppressive effects -LRB- Riegger et al. , 2007 -RRB-	54461
systemic immunosuppressive effects	54461
Riegger	54497
et al. , 2007	54505
et al.	54505
2007	54513
the presence of a urinary system compromised by abnormal urine clearance	54528
the presence	54528
a urinary system compromised by abnormal urine clearance	54544
a urinary system	54544
abnormal urine clearance	54576
chronic urinary infection	54616
The possibility	54643
a systemic infection such as pyelonephritis or pneumonia	54664
a systemic infection	54664
pyelonephritis or pneumonia	54693
the outcome	54744
therapeutic cell transplantation for SCI	54761
therapeutic cell transplantation	54761
SCI	54798
chronic infection	54830
an adverse effect	54871
patients in rehabilitation -LRB- Mylotte et al. , 2001 -RRB-	54892
patients	54892
rehabilitation -LRB- Mylotte et al. , 2001 -RRB-	54904
rehabilitation	54904
Mylotte	54920
et al. , 2001	54928
et al.	54928
2001	54936
The control animals	54946
unexpectedly high scores	54970
the graded angle gridwalk	54998
the	54998
angle gridwalk	55009
The extent of stepping by the control animals	55025
The extent	55025
the control animals	55051
addition to hind-limb stepping movements during ascent of the gridwalk	55093
addition	55093
movements	55124
ascent of the gridwalk	55141
ascent	55141
the gridwalk	55151
there	55164
frequent clonic spastic movements of the hind-limbs	55180
frequent clonic spastic movements	55180
the hind-limbs	55217
The graded gridwalk	55233
The	55233
gridwalk	55244
the inclined plane test	55266
Tator and Rivlin -LRB- Rivlin and Tator , 1977 -RRB-	55312
Tator and Rivlin	55312
Rivlin and Tator	55330
1977	55348
the surface of the grid	55362
the surface	55362
the grid	55377
only a portion	55393
each foot to have contact	55411
contact	55429
the pressure per unit surface area	55457
the pressure	55457
unit surface area	55474
One possible interpretation	55493
only a small part of the foot contacts the grid	55537
only a small part	55537
the foot contacts the grid	55558
the foot contacts	55558
the grid	55576
there	55586
a strong activation	55595
proprioceptive inputs to reflex arcs within the spinal cord	55618
proprioceptive inputs	55618
reflex arcs within the spinal cord	55643
reflex arcs	55643
the spinal cord	55662
this test	55690
reorganization	55719
the isolated distal spinal cord than functional regeneration of longtracts	55737
the isolated distal spinal cord	55737
functional regeneration of longtracts	55774
functional regeneration	55774
longtracts	55801
this respect	55816
our findings using an inclined gridwalk	55829
our findings	55829
an inclined gridwalk	55848
those of Ramon-Cueto -LRB- Ramon-Cueto , 2000 -RRB-	55881
those	55881
Ramon-Cueto -LRB- Ramon-Cueto , 2000 -RRB-	55890
Ramon-Cueto	55890
Ramon-Cueto	55903
2000	55916
The gridwalk test	55923
the analysis	55966
stepping errors	55993
e.g. footfalls -LRB- unpublished data -RRB- -LRB- DeLucia et al. , 2003 -RRB-	56010
e.g.	56010
footfalls -LRB- unpublished data -RRB- -LRB- DeLucia et al. , 2003 -RRB-	56015
footfalls -LRB- unpublished data -RRB-	56015
footfalls	56015
unpublished data	56026
DeLucia	56045
et al. , 2003	56053
et al.	56053
2003	56061
the CST	56080
some effect of the transplantation	56095
some effect	56095
the transplantation	56110
regeneration	56131
Behavioral recovery	56159
the absence of CST axonal regeneration	56191
the absence	56191
CST axonal regeneration	56206
CST fibers	56268
recovery of weightsupported hind-limb locomotion	56301
recovery	56301
weightsupported hind-limb locomotion	56313
The transplanted cells	56351
the collateralization of the CSTand	56385
the collateralization	56385
the CSTand	56410
the appearance of the terminals	56421
the appearance	56421
the terminals	56439
The current literature	56454
conflicting data	56486
the capacity of transplanted OEG	56513
the capacity	56513
transplanted OEG	56529
CST axonal regeneration	56557
Raisman	56582
2000	56591
Ramon-Cueto	56597
et al. , 2000 ; Nash et al. , 2002 ; Deumens et al. , 2006 ; Ruitenberg et al.	56609
et al. , 2000	56609
et al.	56609
2000	56617
Nash et al. , 2002	56623
Nash	56623
et al. , 2002	56628
et al.	56628
2002	56636
Deumens et al. , 2006	56642
Deumens	56642
et al. , 2006	56650
et al.	56650
2006	56658
Ruitenberg et al.	56664
Ruitenberg	56664
et al.	56675
2005	56683
The observations	56690
the current study concur	56710
those studies	56740
CST regeneration	56763
transplantation	56812
thoracic lesions	56841
Nieto-Sampedro	56859
2003 ; Takami et al. , 2002 ; Barakat et al. , 2005 ; Fouad et al.	56875
2003	56875
Takami et al. , 2002 ; Barakat et al. , 2005 ; Fouad et al.	56881
Takami	56881
et al. , 2002 ; Barakat et al. , 2005 ; Fouad et al.	56888
et al. , 2002	56888
et al.	56888
2002	56896
Barakat et al. , 2005	56902
Barakat	56902
et al. , 2005	56910
et al.	56910
2005	56918
Fouad et al.	56924
Fouad	56924
et al.	56930
2005	56938
those	56969
collateral formation	56994
OEG transplantation	57043
the spinal cord	57066
Chuah	57083
et al. , 2004	57089
et al.	57089
2004	57097
facial nerve	57107
Guntinas-Lichius	57121
et al. , 2001	57138
et al.	57138
2001	57146
The reduced cavity volumes following OEG transplantation	57153
The reduced cavity volumes	57153
OEG transplantation	57190
a neurotrophic effect	57230
the role of trophic molecules	57263
the role	57263
trophic molecules	57275
exogenous NT-3	57294
intact and lesioned CST	57356
Jeffery and Fitzgerald , 2001 ; Schnell et al. , 1994	57381
Jeffery and Fitzgerald	57381
2001 ; Schnell et al.	57405
2001	57405
Schnell et al.	57411
Schnell	57411
et al.	57419
1994	57427
OEGS	57443
levels of NT-3 close	57473
levels	57473
NT-3 close	57483
those used in these exogenous applications	57497
those	57497
these exogenous applications	57511
BDNF released by OEGs	57541
BDNF	57541
OEGs	57558
increased CST neuronal survival -LRB- Sasaki et al. , 2006 -RRB-	57582
increased CST neuronal survival	57582
Sasaki	57615
et al. , 2006	57622
et al.	57622
2006	57630
exogenous BDNF at cell bodies	57640
exogenous BDNF	57640
cell bodies	57658
collateral sprouting of injured CST axons -LRB- Vavrek et al. , 2006 -RRB-	57680
collateral	57680
injured CST axons -LRB- Vavrek et al. , 2006 -RRB-	57704
injured CST axons	57704
Vavrek	57723
et al. , 2006	57730
et al.	57730
2006	57738
6 -RRB-	57745
and limited regeneration of 5-HT fibers	57767
limited regeneration of 5-HT fibers	57771
limited regeneration	57771
5-HT fibers	57795
transplanted animals	57823
this	57844
the extent of behavioral recovery	57886
the extent	57886
behavioral recovery	57900
5-HT fiber regeneration	57921
previous studies	57966
OEG s	57992
Ramon-Cueto	58017
et al. ,1998 ; Fouad et al. , 2005 ; Lu et al. , 2002 ; Plant et al. , 2003	58029
et al. ,1998	58029
et al.	58029
,1998	58035
Fouad et al. , 2005	58042
Fouad	58042
et al. , 2005	58048
et al.	58048
2005	58056
Lu et al. , 2002	58062
Lu	58062
et al. , 2002	58065
et al.	58065
2002	58073
Plant et al. , 2003	58079
Plant	58079
et al. , 2003	58085
et al.	58085
2003	58093
Few studies	58100
5-HT fiber regeneration	58128
behavioral recovery -LRB- Fouad et al. , 2005 -RRB- and even fewer	58157
behavioral recovery -LRB- Fouad et al. , 2005 -RRB-	58157
behavioral recovery	58157
Fouad	58178
et al. , 2005	58184
et al.	58184
2005	58192
even fewer	58202
a step of retransection	58224
a step	58224
retransection	58234
these regenerated fibers	58263
the observed recovery -LRB- Lu et al. , 2001 -RRB-	58306
the observed recovery	58306
Lu	58329
et al. , 2001	58332
et al.	58332
2001	58340
this study	58350
the number	58362
regenerated fiberswas	58376
the extent of open field	58418
the extent	58418
open field	58432
locomotor recovery -LRB- Fouad et al. , 2005 -RRB-	58443
locomotor recovery	58443
Fouad	58463
et al. , 2005	58469
et al.	58469
2005	58477
the recovery	58492
such fibers	58523
all others crossing the transection	58540
all others	58540
the transection	58560
the transplant	58608
the neurocircuitry	58632
the isolated spinal cord segment	58658
the isolated spinal cord	58658
segment	58683
7 -RRB- POEG transfection	58692
their unequivocal identification	58721
GFP	58755
at least 42 days following transplantation of transfected OEGs in nude rats	58777
at least 42 days	58777
transplantation of transfected OEGs in nude rats	58804
transplantation	58804
OEGs in nude rats	58835
OEGs	58835
nude rats	58843
the labeling pattern	58857
Hoechst	58904
Previous reports	58913
OEG	58950
the spinal cord stump	58967
the transection site	58994
transplantation -LRB- Ramon-Cueto et al. , 2000 -RRB-	59025
transplantation	59025
Ramon-Cueto	59042
et al. , 2000	59054
et al.	59054
2000	59062
Most authors who have transplanted OEG directly into or adjacent to lesion sites	59069
Most authors	59069
OEG	59104
lesion sites	59137
minimal migration	59161
Plant	59180
et al. , 2003 ; Deng et al. , 2006 ; Lu et al. , 2006 ; Richter et al. , 2005	59186
et al. , 2003	59186
et al.	59186
2003	59194
Deng et al. , 2006	59200
Deng	59200
et al. , 2006	59205
et al.	59205
2006	59213
Lu et al. , 2006	59219
Lu	59219
et al. , 2006	59222
et al.	59222
2006	59230
Richter et al. , 2005	59236
Richter	59236
et al. , 2005	59244
et al.	59244
2005	59252
the current study	59262
Hoechst-positive cells	59280
the transection site	59317
the central canal	59342
the pia mater	59364
the spinal cord parenchyma up to 5 mm	59390
the spinal cord parenchyma	59390
5 mm	59423
the transection site	59433
the distribution of GFP-transfected primate OEG	59464
the distribution	59464
GFP-transfected primate OEG	59484
Hoechstpositive cells within the central canal	59522
Hoechstpositive cells	59522
the central canal	59551
GFP	59574
the most intense migration of GFP-positive cells	59592
the most intense migration	59592
GFP-positive cells	59622
scar tissue and nerve roots	59661
some cells	59698
the spinal cord	59723
Some GFP reaction product	59740
probable macrophages	59788
Hoechst labeling	59810
an unreliable marker of transplanted OEGs in this study	59831
an unreliable marker	59831
transplanted OEGs in this study	59855
transplanted OEGs	59855
this study	59876
Nerve roots	59888
a superior compartment for survival of OEG	59913
a superior compartment	59913
survival of OEG	59940
survival	59940
OEG	59952
This observation	59957
us	59980
the cells	60001
an effect	60021
dorsal root afferent fibers	60034
spinal reflex arcs	60081
Li	60101
et al. , 2004	60104
et al.	60104
2004	60112
Navarro et al. , 1999	60118
Navarro	60118
et al. , 1999	60126
et al.	60126
1999	60134
Ramon-Cueto and Nieto-Sampedro , 1994	60140
Ramon-Cueto and Nieto-Sampedro	60140
1994	60172
Riddell et al. , 2004	60178
Riddell	60178
et al. , 2004	60186
et al.	60186
2004	60194
Such an effect	60201
both rostral and caudal	60228
the transection site	60255
locomotor activity	60287
Novel cellular interactions	60310
the EM level	60355
Direct cellular interactions	60369
a critical factor	60417
OEGs ability	60438
regeneration -LRB- Li et al. , 2005a , b ; Lipson et al. , 2003 -RRB-	60462
regeneration	60462
Li	60476
et al. , 2005a , b ; Lipson et al. , 2003	60479
et al.	60479
2005a , b ; Lipson et al.	60487
2005a , b	60487
2005a	60487
b	60493
Lipson et al.	60496
Lipson	60496
et al.	60503
2003	60511
OEG	60518
both support axonal growth	60541
formmyelin	60584
Devon and Doucette ,1992 ; Franklin et al. , 1996 ; Barnett et al.	60596
Devon and Doucette ,1992	60596
Devon	60596
Doucette ,1992	60606
Franklin et al. , 1996	60621
Franklin	60621
et al. , 1996	60630
et al.	60630
1996	60638
Barnett et al.	60644
Barnett	60644
et al.	60652
2000 ; Kato et al.	60660
2000	60660
Kato et al.	60666
Kato	60666
et al.	60671
2000 ; Franklin , 2003	60679
2000	60679
Franklin , 2003	60685
Franklin	60685
2003	60695
Cells with unusual dark cytoplasm	60702
Cells	60702
unusual dark cytoplasm	60713
two patterns	60753
One , simultaneously	60767
One	60767
axons	60799
cytoplasmic contacts with astrocytes in the absence of perineurial cells	60816
cytoplasmic contacts	60816
astrocytes in the absence of perineurial cells	60842
astrocytes	60842
the absence of perineurial cells	60856
the absence	60856
perineurial cells	60871
Two	60890
perineurial encircled fascicles surrounding unmyelinated axons	60902
perineurial encircled fascicles	60902
unmyelinated axons	60946
Contacts with astrocyte processes Some axonal ensheathing cells	60966
Contacts	60966
astrocyte processes Some axonal ensheathing cells	60980
astrocyte processes	60980
Some axonal ensheathing cells	61000
direct contact with astrocyte processes	61034
direct contact	61034
astrocyte processes	61054
the injury region	61077
direct astrocyte contacts	61109
basal lamina	61155
transplanted OEG	61194
SC	61269
the injured spinal cord -LRB- unpublished data -RRB-	61294
the injured spinal cord	61294
unpublished data	61319
This observation	61338
the authors	61359
such astrocyte contacts	61391
OEG ensheath	61430
they	61454
OEG form	61482
they	61498
a phenotype	61516
SC	61539
a surrounding basal lamina	61548
perineuria precluding direct contact with astrocytes	61579
perineuria	61579
direct contact	61601
astrocytes	61621
The cells	61633
ensheathing	61652
dense cytoplasm	61668
an attribute of the xenografted primate cells	61697
an attribute	61697
the xenografted primate cells	61713
similar cellswere	61749
comparable regions of control-injected spinal cords	61779
comparable regions	61779
control-injected spinal cords	61801
such cells	61841
extensive previous studies	61860
transplanted	61892
human Schwann cell transplantation	61905
nude rats -LRB- Guest et al. , 1997a , b -RRB-	61943
nude rats	61943
Guest	61954
et al. , 1997a , b	61960
et al.	61960
1997a	61968
b	61974
That none	61978
the cells	61991
dense cytoplasm found within astrocytic parenchyma weremyelinating	62006
dense cytoplasm	62006
astrocytic parenchyma weremyelinating	62035
their	62088
in-migrating endogenous Schwann cells	62100
The presence of membrane specializations	62139
The presence	62139
membrane specializations	62155
they	62191
apoptotic dying cells	62215
They	62238
transplanted fibroblasts -LRB- FB -RRB-	62262
transplanted fibroblasts	62262
FB	62288
FB	62300
punctate adhesions	62325
astrocytes	62349
FB	62368
axons	62389
both FB and SC	62409
astrocytes	62461
considerable basal lamina and collagen	62475
considerable basal lamina	62475
collagen	62505
these cells	62521
OEG interacting with host astrocytes	62560
OEG	62560
host astrocytes	62581
Perineurial cells	62598
The majority of axons in the transection site	62616
The majority	62616
axons in the transection site	62632
axons	62632
the transection site	62641
fascicles	62682
perineurial-like cells	62706
Such cells	62730
the function	62769
ensheathing cell grafts	62785
Field	62810
et al. , 2003	62816
et al.	62816
2003	62824
Lakatos et al. , 2003a , b	62830
Lakatos	62830
et al. , 2003a , b	62838
et al.	62838
2003a	62846
b	62852
Li et al. , 1998	62855
Li	62855
et al. , 1998	62858
et al.	62858
1998	62866
Barnett and Chang , 2004	62872
Barnett and Chang	62872
2004	62891
a type of ensheathing cell	62911
a type	62911
ensheathing cell	62921
The perineurial cells	62939
dark cytoplasm	62968
non-myelinating cells	62997
dark cytoplasm that loosely ensheathed several axons	63024
dark cytoplasm	63024
several axons	63063
The deposition of basal lamina in the perineuriawas similar to what	63078
The deposition	63078
basal lamina in the perineuriawas similar to what	63096
basal lamina	63096
the perineuriawas similar to what	63112
the perineuriawas	63112
what	63141
the lamina propria and fila olfactoria	63163
the Macaque olfactory system -LRB- Herrera et al. , 2005 -RRB-	63205
the Macaque olfactory system	63205
Herrera	63235
et al. , 2005	63243
et al.	63243
2005	63251
Perineuria	63258
axonal fascicles	63275
the injury area	63314
control animals	63335
they	63355
cells	63367
dark cytoplasm	63378
it	63405
transplanted cells	63421
axons	63451
perineuria	63485
distinct patterns	63499
transplanted cells	63527
It	63565
the possibility	63595
OEG transplantation	63616
in-migration of host SC	63644
in-migration	63644
host SC	63660
some other investigators -LRB- Boyd et al. , 2004 ; Ramer et al. , 2004 -RRB-	63681
some other investigators	63681
Boyd	63707
et al. , 2004 ; Ramer et al. , 2004	63712
et al.	63712
2004 ; Ramer et al.	63720
2004	63720
Ramer et al.	63726
Ramer	63726
et al.	63732
2004	63740
these interesting fascicles	63755
a cooperative interaction	63793
transplanted POEG	63828
axons	63857
in-migrating endogenous Schwann cells	63867
myelination	63915
the same fascicle	63934
This	63953
another capability	63974
the plastic repertoire of ensheathing glia	63996
the plastic repertoire	63996
ensheathing glia	64022
